Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
AC119676.1		ENSG00000284895			1	41585306-41628816	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	16	"blood: 1.9;lung: 3.2;smooth muscle: 1.3"	"Cell line enhanced"	"Detected in some"		"A-431: 3.2;ASC diff: 11.2;U-266/70: 1.7;WM-115: 2.8"									"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"																																			0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	3.2	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.1	0.0	1.3		0.0	0.0	0.0			0.0		0.0	0.0		1.9	0.7	0.0	0.9	0.0	0.0	0.0	3.2	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MBD3L5		ENSG00000237247	"Methyl-CpG binding domain protein 3 like 5"	A6NJ08	19	7030578-7033011	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	10	"smooth muscle: 1.0;testis: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051259	Uncertain									"HPA051259: AB_2681411"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SMIM28		ENSG00000262543	"Small integral membrane protein 28"	A0A1B0GU29	6	138377905-138383075	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	9	"intestine: 6.2;lymphoid tissue: 2.4;smooth muscle: 1.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.1;SCLC-21H: 2.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																	"unprognostic (2.50e-2)"		"unprognostic (5.48e-2)"				0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	6.2			0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.1	0.0	0.0		0.3	3.1		0.0	0.0	0.0	0.0	1.5	1.9	0.0	0.0	0.3	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TEX15	CT42	ENSG00000133863	"Testis expressed 15, meiosis and synapsis associated"	Q9BXT5	8	30831544-30913003	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 5.4;endometrium 1: 10.0;pituitary gland: 6.9;smooth muscle: 8.5;testis: 21.3"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.7;HEL: 19.7;K-562: 5.5;NTERA-2: 3.7;SCLC-21H: 4.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA036800	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA036800: AB_10671714"	"unprognostic (3.10e-1)"	"unprognostic (2.56e-1)"		"unprognostic (3.30e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.45e-2)"		"unprognostic (2.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-5)"	"unprognostic (8.88e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.92e-1)"	0.1	0.1	0.7	0.2	5.4	0.1	0.1	0.1	1.1	1.2	0.1	0.0	0.0	0.1	10.0	0.6	0.2	0.1	0.8	0.1	1.7	0.5	0.1	0.1	0.1	0.1	0.3	0.3	0.4	0.1	0.1	6.9	0.1	0.9	0.1	0.1	0.3	0.1	0.5	0.1	0.1	0.2	8.5	0.4	0.4	0.9	21.3	1.4	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	8.7	1.1	0.0	1.1	3.1	19.7	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.1	0.1	0.1	3.7	0.3	0.0	0.0	0.0	0.0	0.0	4.3	1.4	0.0	0.0	3.7	0.2	1.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.4	0.1	1.1	1.7	0.5	0.3	0.3	0.9	1.4
FRMD7	"FLJ43346, NYS, NYS1"	ENSG00000165694	"FERM domain containing 7"	Q6ZUT3	X	132076993-132128020	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"endometrium 1: 7.4;kidney: 6.6;smooth muscle: 5.5"	"Cell line enhanced"	"Detected in some"		"AF22: 1.1;HSkMC: 1.7;U-87 MG: 5.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	29	"olfactory region: 80.8"	"Region enriched"	"Detected in single"	100	"olfactory region: 45.5"	HPA000886	Uncertain									"HPA000886: AB_1079269"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"			"unprognostic (1.36e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.54e-2)"			"unprognostic (3.00e-1)"			0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0			0.0	7.4	1.1	0.0	1.1	0.0	0.1	0.0	0.1	6.6	1.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.5	0.0		0.0	1.1	0.0	0.5	0.0	5.5	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0										
GALR2	GALNR2	ENSG00000182687	"Galanin receptor 2"	O43603	17	76074794-76077541	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.5;intestine: 13.1;lymphoid tissue: 9.8;smooth muscle: 6.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.1;NTERA-2: 4.6;THP-1: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA044513	Approved									"HPA044513: AB_10962510"	"unprognostic (1.26e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.32e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.14e-2)"	0.3	0.1	0.0	9.8	0.1	3.5	0.0	0.0	0.3	0.3	13.1	0.0	0.0	0.6	0.0	0.0	1.1	0.1	0.5	0.1	1.4	0.8	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.3	0.0	0.1	0.4	0.6	0.2	0.1	0.0	0.1	0.0	0.0	0.3	9.0	6.4	1.4	0.2	0.4	0.3	0.0	0.0	0.0	1.1	1.2	1.0	0.2	0.0	1.1	1.4	0.9	0.5	0.4	0.7	0.2	1.9	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.3	0.0	2.1	0.4	0.6	0.3	0.0	3.1	0.0	0.1	0.0	0.3	2.5	0.0	1.5	2.8	0.3	0.6	0.5	0.0	0.0	0.3	0.0	0.1	0.1	0.5	0.1	1.1	0.2	0.3	4.6	2.9	0.1	0.6	0.8	0.0	0.2	0.2	0.1	1.7	0.7	0.3	0.6	6.8	0.2	0.2	0.6	0.2	0.4	0.7	0.4	2.6	0.0	0.1	0.0	0.0	0.9	0.0	0.4	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.4	0.5	0.4	1.1	0.0	0.7	0.0	0.1	0.0	0.3	1.4	0.8	0.2	0.0	0.6	0.0
GPR139	PGR3	ENSG00000180269	"G protein-coupled receptor 139"	Q6DWJ6	16	20031485-20073917	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 2.8;endometrium 1: 2.1;smooth muscle: 1.0"	"Cell line enriched"	"Detected in single"	10	"NTERA-2: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA046596	Uncertain									"HPA046596: AB_2679713"					"unprognostic (2.94e-1)"													0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0			0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.2	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PGR	"NR3C3, PR"	ENSG00000082175	"Progesterone receptor"	P06401	11	101029624-101130524	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 50.7;endometrium 1: 116.4;smooth muscle: 31.2"	"Cell line enriched"	"Detected in single"	349	"T-47d: 60.8"	"Group enriched"	"Detected in some"	13	"breast cancer: 10.1;endometrial cancer: 11.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000068, HPA004751, HPA008428, HPA017176, CAB055100"	Enhanced									"CAB000068: AB_442124, CAB055100: AB_2532076, HPA004751: AB_1079681, HPA008428: AB_1079680, HPA017176: AB_1855728"	"unprognostic (2.59e-2)"	"unprognostic (9.80e-3)"	"unprognostic (5.23e-3)"	"prognostic favourable (5.76e-8)"	"unprognostic (2.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.71e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.44e-3)"	0.8	0.7	0.2	0.3	0.6	0.0	5.0	0.2	0.7	50.7	1.3	0.2	0.4	0.0	116.4	6.1	0.5	13.2	0.4	2.0	0.5	0.6	0.4	0.1	1.2	0.3	0.4	0.1	10.6	0.8	0.0	2.8	1.8	0.8	3.8	0.1	0.7	3.5	5.5	0.3	0.3	1.2	31.2	0.9	0.5	0.4	1.5	0.3	0.1	0.3	0.8	0.2	1.1	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	60.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.7	0.5	0.6	0.4	0.1	0.8	0.3
TBX4		ENSG00000121075	"T-box 4"	P57082	17	61452404-61485110	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"lung: 31.1;placenta: 17.0;prostate: 15.0;smooth muscle: 26.0;urinary bladder: 18.6"	"Cell line enhanced"	"Detected in some"		"BJ: 5.3;Hep G2: 2.1;THP-1: 10.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"basal ganglia: 1.6"	"CAB032413, HPA044457"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"CAB032413: AB_2200705, HPA044457: AB_2678948"	"unprognostic (1.03e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.07e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.14e-2)"	"unprognostic (7.77e-3)"	"unprognostic (7.41e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.46e-8)"	"unprognostic (1.92e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.15e-2)"	"unprognostic (5.39e-2)"	0.5	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	31.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.0	0.6	15.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	26.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	18.6	4.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.9	0.1	0.0	0.0	5.3	0.5	0.4	0.4	1.9	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.8	0.0	0.0	2.1	0.5	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.5	0.0	10.5	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
ZCCHC12	"FLJ16123, PNMA7A, SIZN, SIZN1"	ENSG00000174460	"Zinc finger CCHC-type containing 12"	Q6PEW1	X	118823790-118826968	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 51.3;endometrium 1: 53.4;fallopian tube: 60.7;smooth muscle: 72.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.4;HEK 293: 13.9;NTERA-2: 4.4;SH-SY5Y: 3.5"	"Cancer enriched"	"Detected in many"	76	"thyroid cancer: 256.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"naive CD8 T-cell: 4.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 4.1"									"HPA031016, HPA034940"	Uncertain		Approved	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA031016: AB_2673698, HPA034940: AB_10671098"	"unprognostic (1.29e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.44e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.34e-4)"	"unprognostic (9.18e-13)"	"unprognostic (4.14e-3)"	"unprognostic (1.63e-1)"	"prognostic favourable (3.42e-5)"	"unprognostic (1.18e-1)"	0.9	4.8	30.5	1.2	20.2	0.8	1.0	20.3	17.3	9.7	1.1	1.6	0.9	1.0	53.4	11.6	0.8	60.7	1.0	0.8	28.7	51.3	0.8	0.8	0.9	1.1	4.4	11.6	6.7	0.8	0.8	7.9	0.8	14.7	1.0	1.0	1.1	0.8	1.1	0.8	0.8	1.1	72.5	4.5	0.9	0.8	1.0	0.8	0.0	2.9	0.0	1.1	0.8	1.7	0.6	0.0	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.7	0.0	0.0	0.4	0.0	0.0	5.4	0.0	0.2	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.2	4.4	0.0	0.1	0.0	0.0	0.0	0.0	1.9	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.7	4.1	0.0	0.0	0.0	0.0	0.0	0.2	30.5	20.2	20.3	17.3	28.7	51.3	4.4	11.6	14.7	0.8
APCDD1L	FLJ90166	ENSG00000198768	"APC down-regulated 1 like"	Q8NCL9	20	58459101-58515131	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"salivary gland: 39.2;smooth muscle: 10.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 42.4;hTEC/SVTERT24-B: 15.0;HUVEC TERT2: 15.2;TIME: 29.8;U-87 MG: 18.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA067015	Uncertain		Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA067015: AB_2685764"	"unprognostic (2.61e-1)"	"unprognostic (8.26e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.35e-5)"	"unprognostic (4.09e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.06e-4)"	"unprognostic (7.63e-4)"	"unprognostic (2.14e-2)"	"unprognostic (7.62e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.55e-13)"	"unprognostic (5.01e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.81e-3)"	0.5	0.6	0.2	0.6	0.2	0.0	5.2	0.6	0.1	3.3	1.2	0.1	0.0	0.1	2.4	0.2	0.8	0.0	2.1	5.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.5	0.0	0.1	3.6	0.7	3.2	39.2	1.7	0.6	0.9	0.8	10.9	0.3	0.0	0.6	0.1	0.0	0.0	0.1	1.0	0.6	6.1	5.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	9.0	0.0	0.9	0.6	0.0	2.7	0.0	0.0	42.4	0.4	0.0	1.4	1.4	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	1.2	0.0	15.0	0.2	15.2	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.8	6.4	0.4	0.0	8.3	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0
ASIC2	"ACCN, ACCN1, ASIC2a, BNaC1, BNC1, hBNaC1, MDEG"	ENSG00000108684	"Acid sensing ion channel subunit 2"	Q16515	17	33013087-34174964	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 13.1;cervix, uterine: 6.8;endometrium 1: 9.5;smooth muscle: 3.9"	"Group enriched"	"Detected in some"	4	"NTERA-2: 4.2;PC-3: 1.1;RPTEC TERT1: 3.8"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052112	Enhanced									"HPA052112: AB_2681733"	"unprognostic (3.40e-1)"	"unprognostic (2.45e-2)"	"unprognostic (8.50e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.88e-3)"	"unprognostic (5.29e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	0.4	1.9	8.1	0.4	6.3	0.3	0.7	8.7	13.1	6.8	0.7	1.1	0.0	1.2	9.5	0.5	0.4	1.5	0.5	0.4	7.7	10.0	1.2	0.4	0.5	0.4	4.6	5.5	0.4	0.4	0.3	0.5	0.5	3.7	0.6	0.8	0.2	0.3	1.7	0.3	0.6	1.2	3.9	2.3	0.4	0.5	1.1	0.8	0.0	0.4	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.2	1.1	0.0	0.0	0.5	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	6.3	8.7	9.6	7.7	10.0	4.6	5.5	3.7	0.8
COL19A1		ENSG00000082293	"Collagen type XIX alpha 1 chain"	Q14993	6	69866571-70209976	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 23.1;brain: 14.4;lymphoid tissue: 18.8;smooth muscle: 37.8;urinary bladder: 12.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.5;RH-30: 14.2;SCLC-21H: 4.0;SK-MEL-30: 11.9;WM-115: 10.0"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Region enhanced"	"Detected in many"		"cerebellum: 14.4"	"Group enriched"	"Detected in some"	156	"memory B-cell: 7.9;naive B-cell: 23.1"	"Lineage enriched"	"Detected in single"	232	"B-cells: 23.1"	"Low region specificity"	"Detected in many"							HPA042422	Uncertain				"Secreted to extracellular matrix"					"HPA042422: AB_10794798"	"unprognostic (2.65e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.35e-1)"	"unprognostic (8.91e-2)"	4.2	0.7	1.1	18.8	2.7	1.1	0.5	14.4	4.1	0.5	1.6	0.0	0.0	0.8	0.5	0.2	0.6	0.7	0.6	2.6	6.0	1.0	4.5	0.6	0.6	7.3	0.7	1.1	0.5	0.9	0.2	4.2	0.4	0.7	5.2	2.2	0.0	0.8	0.4	3.7	0.5	2.3	37.8	0.6	4.2	4.4	1.5	0.0	1.3	0.6	0.0	8.8	12.4	2.3	23.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	5.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	14.2	0.0	0.0	0.0	4.0	2.9	0.0	0.0	11.9	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	2.7	14.4	4.1	6.0	1.0	0.7	1.1	0.7	0.0
PLCD4		ENSG00000115556	"Phospholipase C delta 4"	Q9BRC7	2	218607765-218637184	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"retina: 23.0;skeletal muscle: 62.5;smooth muscle: 33.1"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009914, HPA038139, HPA038140"	Enhanced		Approved	"Nuclear membrane,Plasma membrane,Cytosol"				Cytosol	Cytosol	"CAB009914: AB_2252306, HPA038139: AB_2675855, HPA038140: AB_2675856"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.65e-5)"	"unprognostic (7.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.87e-3)"	"unprognostic (7.54e-5)"	"unprognostic (3.28e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.32e-2)"	"unprognostic (8.46e-3)"	"unprognostic (3.09e-1)"	1.1	2.5	1.5	1.0	1.6	0.5	1.0	0.9	2.4	0.6	6.4	0.3	3.8	0.9	0.8	1.1	3.7	0.6	0.9	0.9	1.0	1.5	3.9	0.5	0.7	0.7	1.6	1.0	0.7	0.4	1.4	4.7	0.6	2.6	6.4	1.5	23.0	1.4	0.6	62.5	0.8	1.4	33.1	1.1	0.5	3.5	3.9	0.5	0.0	1.4	6.8	0.5	9.6	5.3	0.9	1.2	0.3	0.4	0.9	0.9	1.0	0.6	1.5	2.1	0.4	0.2	1.4	1.2	1.2	2.6	0.4	1.4	2.4	0.3	1.4	1.8	0.4	1.0	0.0	1.5	0.3	0.5	1.8	1.2	3.5	1.9	0.2	1.2	0.6	3.0	0.1	1.9	0.5	2.7	1.0	1.1	2.2	1.8	0.4	1.2	0.7	3.4	0.9	0.8	0.5	4.3	3.0	2.3	21.1	1.0	0.8	0.3	2.5	0.5	6.0	1.5	1.2	0.7	0.7	0.5	0.8	0.9	4.6	0.3	1.6	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.3	0.9	0.3	0.9	0.7	0.8	0.3	0.9	0.0	1.2	0.7	1.0	1.5	1.6	0.9	2.4	1.0	1.5	1.6	1.0	2.6	0.5
AARD	"C8orf85, LOC441376"	ENSG00000205002	"Alanine and arginine rich domain containing protein"	Q4LEZ3	8	116938199-116944487	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 18.4;testis: 43.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 19.7;SK-BR-3: 11.2;U-2 OS: 5.4;U-266/84: 4.0"	"Cancer enriched"	"Detected in many"	8	"breast cancer: 27.0"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	4	"midbrain: 7.3"	HPA068290			Approved	"Lipid droplets"				"Lipid droplets"	"Lipid droplets"	"HPA068290: "	"unprognostic (5.81e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.28e-8)"	"unprognostic (3.42e-2)"	"unprognostic (4.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.29e-2)"	"unprognostic (8.57e-3)"	"unprognostic (4.20e-1)"	"unprognostic (2.23e-6)"	"unprognostic (1.67e-1)"	"unprognostic (9.78e-3)"	"unprognostic (3.77e-2)"	"unprognostic (5.27e-4)"	0.4	0.8	0.7	1.8	1.2	0.3	4.9	0.0	0.9	0.3	4.5	0.0	0.0	0.2	1.1	0.8	8.1	0.2	0.4	0.1	0.5	0.6	1.3	0.1	2.9	1.0	0.4	0.5	0.1	0.1	0.1	0.0	0.6	0.5	8.4	0.7	4.0	2.1	0.2	0.2	1.1	0.8	18.4	0.1	0.3	7.2	43.6	0.1	0.0	0.2	0.2	0.5	10.2	5.6	1.1	1.0	3.3	0.9	1.5	2.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.2	1.6	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.5	0.0	0.2	0.1	2.3	0.0	0.2	0.4	0.0	0.1	0.1	0.0	0.0	2.3	0.1	0.4	0.8	0.1	1.1	2.0	0.0	0.0	0.1	0.0	0.0	1.9	0.3	0.0	11.2	0.0	0.5	0.0	0.0	0.1	5.4	0.2	0.0	1.6	4.0	0.0	2.9	0.1	0.3	3.3	0.9	0.6	0.6	0.4	0.3	0.6	0.5	0.4	0.2	1.1	0.5	0.6	3.1	1.5	0.6	1.0	2.0	0.1	0.7	1.2	0.0	0.4	0.5	0.6	0.4	0.5	0.5	0.1
AC233724.12		ENSG00000250782			5	17634460-17635053	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"smooth muscle: 1.1"	"Cell line enriched"	"Detected in single"	28	"U-2 OS: 4.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.4	0.0		0.0		0.0	0.0		0.7	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	1.1		0.0	0.0	0.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ACTG2	"ACTA3, ACTL3, ACTSG"	ENSG00000163017	"Actin, gamma 2, smooth muscle, enteric"	P63267	2	73892314-73919865	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 404.6;smooth muscle: 581.1;urinary bladder: 568.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 16.4;BJ hTERT+: 13.4;BJ hTERT+ SV40 Large T+: 53.0;HHSteC: 13.8;U-251 MG: 57.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 255.0;stomach cancer: 237.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	9	"T-reg: 10.9"	"Lineage enriched"	"Detected in single"	17	"T-cells: 10.9"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in many"	6	"midbrain: 17.0"	"HPA041264, HPA041271"	Supported									"HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (5.79e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.50e-1)"	"unprognostic (8.05e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.75e-2)"	"prognostic unfavourable (3.95e-7)"	"unprognostic (9.30e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.57e-3)"	8.7	1.2	0.3	57.4	0.4	0.0	6.8	0.3	0.4	90.0	404.6	0.8	187.4	15.9	188.2	76.1	348.3	45.5	122.5	5.6	0.3	0.3	2.9	0.6	7.0	3.6	0.4	0.6	25.9	1.1	0.0	0.4	10.0	0.9	160.8	52.4	2.8	9.4	271.2	2.4	4.7	80.2	581.1	0.4	0.9	134.9	14.5	0.1	0.1	1.8	2.0	2.3	568.2	35.2	0.2	0.5	0.4	0.6	0.2	10.9	2.3	0.1	0.0	5.4	0.0	0.0	0.0	16.4	3.5	13.4	53.0	9.9	1.7	0.0	0.0	0.2	0.0	0.0	9.5	0.0	7.6	0.0	0.0	0.0	0.8	0.1	13.8	0.0	0.1	0.1	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	2.1	0.0	0.0	0.0	0.1	0.8	0.1	3.5	0.1	0.6	0.0	0.7	0.3	0.0	0.0	0.0	0.3	0.6	0.6	57.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.5	0.4	0.4	0.4	0.2	0.2	1.1	0.4	0.5	0.2	0.6	0.7	0.2	0.2	0.6	0.2	10.9	2.3	0.3	0.4	0.3	0.4	0.3	0.3	0.4	0.6	0.9	0.1
ADAM19	MLTNB	ENSG00000135074	"ADAM metallopeptidase domain 19"	Q9H013	5	157395534-157575775	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 49.4;smooth muscle: 46.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.1;U-251 MG: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 32.3;eosinophil: 37.5;memory B-cell: 14.1;naive B-cell: 15.8;neutrophil: 20.1;plasmacytoid DC: 18.5"	"Group enriched"	"Detected in many"	5	"B-cells: 15.8;dendritic cells: 18.5;granulocytes: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055537			Approved	Vesicles				Vesicles	Vesicles	"HPA055537: AB_2797253"	"unprognostic (4.71e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (3.90e-12)"	"unprognostic (1.44e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-2)"	3.7	2.5	1.3	49.4	1.5	4.8	2.8	6.9	2.4	4.4	15.1	1.1	3.6	3.9	8.6	5.9	4.6	5.9	14.7	18.9	1.6	1.7	1.6	4.3	9.1	19.2	1.6	1.0	3.0	0.5	0.0	1.4	33.0	3.4	5.9	4.9	5.0	6.8	4.6	3.9	0.8	14.0	46.1	2.8	16.8	7.7	1.3	0.5	5.6	3.1	3.3	29.4	17.0	3.9	15.8	18.5	37.5	3.9	0.1	4.4	2.2	10.9	1.7	3.4	0.0	0.2	0.2	21.9	13.1	4.7	8.2	6.1	5.7	9.0	5.7	0.7	6.7	9.3	0.5	0.8	7.5	31.1	0.3	0.0	0.9	0.7	2.0	0.0	0.0	1.5	0.0	6.4	1.3	9.2	1.6	0.8	17.4	0.0	0.0	0.0	3.6	5.7	0.1	19.6	4.8	0.8	0.1	1.5	1.0	0.0	4.7	0.6	0.0	0.1	14.1	8.9	9.6	2.0	59.2	3.5	0.1	20.5	2.0	0.0	3.9	32.3	3.9	37.5	0.4	0.3	1.0	14.1	4.4	1.0	1.1	15.8	0.1	0.1	20.1	0.1	0.0	18.5	4.4	2.2	1.3	1.5	6.9	2.3	1.6	1.7	1.6	1.0	3.4	0.5
ADAM33	"C20orf153, dJ964F7.1, DKFZp434K0521"	ENSG00000149451	"ADAM metallopeptidase domain 33"	Q9BZ11	20	3667965-3682246	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 55.7;smooth muscle: 58.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 30.7;ASC TERT1: 39.7;BJ: 13.5;BJ hTERT+: 23.2;fHDF/TERT166: 13.8;U-2197: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.2"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Low region specificity"	"Detected in all"			"HPA067152, HPA071758"	Approved		Uncertain	"Nuclear speckles,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA067152: AB_2685791, HPA071758: "	"unprognostic (1.10e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.39e-3)"	"unprognostic (7.43e-4)"	"unprognostic (7.14e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.75e-11)"	"unprognostic (1.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.21e-5)"	"unprognostic (3.10e-3)"	10.0	1.5	4.6	9.2	2.6	0.0	20.2	2.8	2.7	55.7	29.5	2.2	20.9	4.7	44.3	12.3	17.0	16.9	17.5	5.3	5.0	0.9	0.9	0.5	3.6	2.2	4.9	3.0	11.8	1.6	0.0	1.6	5.4	7.0	22.8	5.5	3.7	4.2	27.1	3.5	4.8	9.1	58.0	3.3	1.9	9.9	5.4	3.5	0.1	4.0	10.1	2.0	24.9	36.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	39.7	0.1	13.5	23.2	4.0	7.9	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	6.8	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	4.6	2.6	2.8	2.7	5.0	0.9	4.9	3.0	7.0	3.5
ADAMTS19		ENSG00000145808	"ADAM metallopeptidase with thrombospondin type 1 motif 19"	Q8TE59	5	129460265-129738683	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 16.6;endometrium 1: 14.6;smooth muscle: 9.0"	"Group enriched"	"Detected in some"	8	"MCF7: 11.7;SH-SY5Y: 27.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"olfactory region: 4.8"	"Low region specificity"	"Detected in all"			"HPA056171, HPA058438"	Uncertain		Approved	Vesicles,Midbody	"Secreted to extracellular matrix"			"Vesicles, Midbody"	"Vesicles, Midbody"	"HPA056171: AB_2683054, HPA058438: AB_2683718"	"unprognostic (1.14e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.49e-2)"		"unprognostic (3.93e-2)"		"unprognostic (4.17e-2)"	"unprognostic (5.99e-3)"	"unprognostic (5.17e-1)"		"unprognostic (1.14e-1)"	"unprognostic (5.88e-2)"		"unprognostic (3.06e-2)"	0.2	1.2	0.7	0.6	3.6	0.1	0.2	0.0	4.9	16.6	0.5	1.2	0.0	0.4	14.6	0.3	1.5	2.6	0.8	0.5	1.0	0.8	0.7	0.1	0.2	0.2	0.5	4.3	2.8	0.2	0.2	0.1	5.3	1.8	0.4	0.6	0.9	1.1	0.2	0.8	0.2	0.3	9.0	1.0	0.2	0.2	0.4	0.8	0.0	0.1	1.8	0.1	0.9	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	27.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.6	0.0	4.9	1.0	0.8	0.5	4.3	1.8	0.8
ADARB1	"ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1"	ENSG00000197381	"Adenosine deaminase, RNA specific B1"	P78563	21	45073853-45226560	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 59.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 27.3;HHSteC: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029645			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA029645: "	"unprognostic (2.69e-1)"	"unprognostic (7.65e-2)"	"prognostic unfavourable (8.16e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (4.57e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.38e-2)"	12.2	5.3	7.1	10.4	8.4	4.5	8.9	33.1	11.6	11.7	17.2	2.5	5.6	2.9	13.4	6.6	14.0	8.8	11.1	6.7	7.3	8.1	4.6	4.0	19.9	11.8	7.4	8.1	5.3	4.7	19.0	3.7	12.0	13.6	14.7	5.0	11.0	4.6	8.7	11.8	10.8	5.9	59.9	3.5	10.5	11.7	3.8	4.0	3.9	3.8	4.5	8.4	34.6	20.3	6.1	2.1	4.8	0.6	0.5	2.6	0.5	3.1	0.4	2.4	2.9	3.0	2.1	3.3	2.1	3.5	6.7	4.3	4.9	0.5	1.0	5.7	10.3	0.3	3.6	8.7	7.5	0.7	3.2	6.8	27.3	3.2	31.7	4.6	3.3	11.3	3.8	2.4	7.1	7.1	1.5	0.4	19.6	2.3	3.0	4.4	4.0	4.7	0.9	2.3	3.1	1.5	1.0	14.4	3.8	16.7	0.7	5.3	1.6	3.7	7.4	2.2	2.7	9.0	7.8	3.1	1.4	0.8	2.0	10.9	11.9	1.3	0.2	4.8	1.1	0.6	1.8	2.4	2.6	1.6	0.0	6.1	1.8	1.4	0.2	0.5	0.3	2.1	1.6	0.5	7.1	8.4	33.1	11.6	7.3	8.1	7.4	8.1	13.6	4.0
ADGRD1	"DKFZp434B1272, GPR133, PGR25"	ENSG00000111452	"Adhesion G protein-coupled receptor D1"	Q6QNK2	12	130953907-131141469	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 66.1"	"Cell line enhanced"	"Detected in some"		"BJ: 5.0;fHDF/TERT166: 5.7;HeLa: 10.3;HHSteC: 6.6;HMC-1: 14.2;U-2 OS: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 4.1;intermediate monocyte: 4.9;myeloid DC: 2.4;non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 4.9"	"Region enhanced"	"Detected in some"		"basal ganglia: 5.3"	"Low region specificity"	"Detected in all"			HPA042395	Uncertain		Approved	Nucleoplasm,Cytosol		600000	600000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA042395: AB_10796906"	"unprognostic (3.21e-1)"	"unprognostic (1.49e-4)"	"unprognostic (1.32e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (9.27e-4)"	"unprognostic (2.55e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.79e-5)"	"unprognostic (1.31e-3)"	"unprognostic (4.58e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.77e-3)"	12.7	2.1	2.0	3.2	3.1	0.5	8.9	1.1	3.9	11.2	5.5	2.2	3.9	2.2	13.3	14.0	6.8	8.8	45.6	34.8	1.9	1.5	1.6	5.2	18.6	0.6	4.2	2.2	12.5	11.8	0.3	3.5	26.6	2.4	13.3	2.4	13.0	1.6	2.3	11.6	3.8	6.4	66.1	6.4	1.9	10.2	3.8	2.6	0.0	6.3	7.1	2.1	29.5	30.8	0.2	2.4	0.0	4.9	0.5	0.0	1.2	0.0	0.7	0.0	2.5	0.0	0.0	0.1	5.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.3	0.0	6.6	0.0	14.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.1	0.2	0.5	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.5	7.0	1.9	0.1	0.1	1.8	0.9	0.1	0.0	0.0	0.0	4.1	0.0	0.0	4.9	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.0	0.0	0.5	3.6	0.0	0.0	1.2	2.0	3.1	1.1	3.9	1.9	1.5	4.2	2.2	2.4	2.6
ADRB3		ENSG00000188778	"Adrenoceptor beta 3"	P13945	8	37962991-37966965	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"gallbladder: 23.9;ovary: 15.7;smooth muscle: 10.8"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.3;Karpas-707: 1.0;U-2 OS: 1.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"amygdala: 1.3"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA061969	Uncertain									"HPA061969: AB_2732674"	"unprognostic (1.70e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.64e-3)"	"unprognostic (5.41e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.07e-1)"		"unprognostic (1.14e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.29e-8)"	"unprognostic (1.10e-3)"	"unprognostic (2.81e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.06e-3)"	0.4	0.1	1.3	1.9	0.3	0.3	0.3	0.0	0.8	1.6	2.3	0.0	0.0	0.4	0.9	1.9	1.7	5.3	23.9	0.1	0.2	0.1	0.1	0.0	0.2	1.2	0.0	0.0	15.7	0.0	0.0	0.0	4.7	0.0	4.1	0.4	0.0	0.0	0.1	0.0	0.1	0.9	10.8	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.0	0.1	9.9	1.5	0.9	0.2	1.2	0.4	0.8	0.5	0.0	0.2	0.2	0.1	0.1	0.2	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.3	0.0	0.3	0.0	0.3	0.0	0.1	0.1	0.0	0.0	2.3	0.4	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.1	0.4	0.3	0.4	1.3	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.0	1.0	0.3	0.3	0.1	0.1	0.4	0.7	0.2	0.1	0.0	0.9	0.2	0.2	1.2	0.8	0.4	0.2	0.5	0.0	1.3	0.3	0.0	0.8	0.2	0.1	0.0	0.0	0.0	0.0
AGTR2	"AT2, MRX88"	ENSG00000180772	"Angiotensin II receptor type 2"	P50052	X	116170722-116174972	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 20.8;lung: 26.7;smooth muscle: 13.6"	"Cell line enriched"	"Detected in single"	6	"HSkMC: 1.3"	"Group enriched"	"Detected in some"	12	"endometrial cancer: 3.0;lung cancer: 1.9"	"Region enriched"	"Detected in single"	10	"cerebellum: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"cerebellum: 3.8"															"unprognostic (2.13e-1)"				"unprognostic (1.71e-1)"			"unprognostic (3.22e-2)"				"unprognostic (4.37e-2)"			0.3	1.6	0.1	0.8	0.1	0.0	0.1	1.0	0.1	5.3	0.4	0.1	0.1	0.0	20.8	3.3	0.2	3.6	0.4	1.7	0.1	0.0	0.4	0.1	26.7	0.8	0.1	0.1	1.1	1.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	13.6	0.1	0.1	0.6	0.2	0.1	0.4	0.1	1.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392664-38398661	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 113.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021037	Approved		Supported	Nucleoplasm,Vesicles,Mitochondria		210000	210000	Mitochondria	Mitochondria	"HPA021037: AB_1844724"	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favourable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (2.89e-2)"	7.4	4.9	2.1	16.8	2.1	0.6	5.4	1.1	5.4	5.8	25.4	1.7	6.1	7.0	27.3	10.7	21.6	16.7	30.8	11.6	3.1	2.0	18.0	55.2	3.5	5.9	2.4	2.0	12.2	14.6	1.4	1.4	1.6	3.0	22.7	11.5	5.2	5.9	18.2	19.4	3.0	11.2	113.9	2.7	2.8	15.8	7.8	1.7	1.6	6.3	7.0	2.0	54.5	8.3	5.9	9.4	1.2	10.5	7.5	10.2	5.1	23.9	22.3	6.9	11.0	9.8	11.7	5.5	11.5	5.8	9.7	10.0	14.9	4.7	15.1	6.9	16.1	3.4	22.7	24.3	9.7	16.9	9.8	7.5	16.4	44.2	7.1	11.9	8.5	13.9	5.3	7.9	6.9	9.2	21.6	14.8	14.7	9.1	0.0	4.8	20.5	10.0	4.9	41.8	11.5	8.7	10.8	15.1	7.0	8.7	5.8	6.7	5.5	9.3	6.2	11.2	18.6	9.3	14.3	2.2	4.3	6.0	5.8	12.2	7.6	0.2	4.2	0.2	7.3	9.1	10.2	5.9	7.0	6.6	9.4	3.1	5.8	6.8	1.2	7.5	10.5	1.3	4.8	5.1	2.1	2.1	1.1	5.4	3.1	2.0	2.4	2.0	3.0	1.7
BAG2		ENSG00000112208	"BCL2 associated athanogene 2"	O95816	6	57172326-57189833	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 67.0;urinary bladder: 51.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018862, HPA019918"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA018862: AB_2669957, HPA019918: AB_2670317"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.32e-3)"	"prognostic unfavourable (6.72e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.79e-5)"	"unprognostic (6.20e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.97e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavourable (1.26e-4)"	"unprognostic (6.24e-3)"	3.4	3.5	3.7	8.7	2.8	1.2	4.6	4.1	3.4	18.4	24.5	0.8	14.8	1.9	29.4	9.5	13.4	5.9	6.9	17.2	3.3	3.5	3.7	3.8	4.1	2.3	3.3	2.3	15.4	1.5	0.6	4.5	6.7	3.4	23.7	4.3	2.6	1.5	15.1	9.9	1.7	5.7	67.0	3.4	1.3	7.4	6.7	2.6	1.6	7.6	6.0	1.9	51.0	17.1	5.9	1.4	0.9	0.4	3.3	6.1	1.9	9.3	5.2	2.2	7.8	5.5	15.9	6.2	15.2	14.5	11.0	10.5	6.7	4.8	3.1	14.6	24.0	1.7	12.6	1.3	10.6	9.9	9.3	9.1	7.8	15.1	8.5	8.0	2.1	7.7	0.7	9.0	8.5	8.5	18.4	4.5	10.8	0.7	5.6	6.7	8.4	5.4	5.2	6.2	6.3	13.1	1.5	2.8	2.5	6.8	0.5	5.5	1.2	7.0	11.6	6.3	10.3	13.2	15.0	3.0	2.9	6.9	5.6	3.2	0.6	0.1	0.3	0.9	3.3	0.4	3.9	5.9	3.1	3.3	1.4	4.3	6.1	5.1	0.3	3.3	0.1	0.5	3.2	1.9	3.7	2.8	4.1	3.4	3.3	3.5	3.3	2.3	3.4	2.6
BDNF		ENSG00000176697	"Brain derived neurotrophic factor"	P23560	11	27654893-27722058	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.5;smooth muscle: 10.5"	"Cell line enhanced"	"Detected in many"		"BJ: 22.4;BJ hTERT+ SV40 Large T+: 17.2;BJ hTERT+ SV40 Large T+ RasG12V: 13.1;HBF TERT88: 16.5;U-138 MG: 24.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009564, HPA031440, HPA056104"	Enhanced		Supported	"Nuclear speckles,Mitochondria"	"Secreted to blood"			"Nuclear speckles, Mitochondria"	"Nuclear speckles, Mitochondria"	"CAB009564: AB_2064213, HPA031440: AB_2673883, HPA056104: "	"unprognostic (1.25e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.88e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.84e-3)"	0.9	1.3	5.0	0.6	4.5	0.5	0.6	9.4	14.5	1.6	0.8	0.6	0.7	0.8	0.7	8.2	1.4	0.5	2.1	5.8	8.5	5.7	0.9	0.5	4.1	0.4	2.5	4.7	1.2	1.0	0.2	2.3	3.7	12.7	4.9	0.4	3.0	0.9	4.2	1.3	2.1	0.5	10.5	1.0	0.6	0.9	1.3	0.0	0.0	2.3	0.0	0.4	3.2	1.2	0.1	0.4	0.0	0.2	0.1	1.0	0.1	1.6	6.6	0.2	0.0	2.3	1.9	0.0	22.4	4.3	17.2	13.1	0.0	2.6	0.0	2.1	8.1	1.0	0.1	0.2	16.5	0.1	0.1	0.0	2.2	0.0	10.0	0.1	0.1	5.8	2.2	3.8	2.2	0.7	0.0	0.0	2.7	0.0	0.0	0.0	2.1	1.8	0.0	1.3	0.0	2.5	0.0	0.1	0.6	4.3	0.0	0.0	0.1	0.0	7.4	24.1	4.0	9.3	5.0	0.3	0.0	0.0	9.3	0.6	1.3	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.6	0.2	0.1	0.7	0.4	0.0	0.1	0.0	0.4	1.0	0.1	5.0	4.5	9.4	9.4	8.5	5.7	2.5	4.7	12.7	0.0
C3orf70		ENSG00000187068	"Chromosome 3 open reading frame 70"	A6NLC5	3	185078050-185153014	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 26.6"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 19.0;SK-BR-3: 8.3;WM-115: 10.2"	"Cancer enhanced"	"Detected in many"		"glioma: 10.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041861	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA041861: AB_10804119"	"unprognostic (1.45e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.92e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.62e-4)"	"unprognostic (5.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.91e-2)"	"prognostic unfavourable (6.40e-6)"	"unprognostic (1.06e-1)"	"unprognostic (8.48e-2)"	"unprognostic (6.57e-2)"	"unprognostic (7.84e-2)"	4.6	2.3	14.4	4.7	13.8	0.9	2.0	7.9	18.2	7.2	12.1	11.1	7.9	5.3	12.1	6.1	10.1	6.8	6.1	3.3	11.1	10.2	1.6	1.3	2.4	1.3	11.4	7.1	5.9	1.1	4.0	1.4	2.9	10.5	10.2	8.2	5.2	5.5	16.4	1.5	2.9	6.5	26.6	11.1	4.2	4.4	7.5	7.0	0.0	2.4	1.0	1.7	13.2	3.3	1.2	1.2	3.4	1.6	1.7	1.1	0.5	0.0	0.1	2.2	0.0	0.0	0.1	0.1	2.9	0.1	0.5	0.0	1.3	0.0	0.0	0.0	0.3	0.1	1.0	0.0	0.2	0.0	0.7	2.5	0.1	0.7	0.0	0.4	4.2	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	1.0	0.2	0.1	4.6	0.1	0.0	0.4	19.0	0.2	0.9	8.3	0.5	0.6	2.1	0.8	0.0	2.2	0.1	1.4	0.0	0.0	0.0	0.0	0.0	10.2	3.4	1.2	1.7	0.8	1.0	1.0	1.0	0.8	0.8	0.6	1.2	1.0	1.1	3.3	1.7	1.6	1.2	0.7	0.5	14.4	13.8	7.9	9.6	11.1	10.2	11.4	7.1	10.5	7.0
CACNA1H	Cav3.2	ENSG00000196557	"Calcium voltage-gated channel subunit alpha1 H"	O95180	16	1153121-1221772	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 49.5"	"Cell line enhanced"	"Detected in some"		"A549: 10.8;AN3-CA: 15.6;MCF7: 28.6;T-47d: 8.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA039125	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA039125: AB_10795578"	"unprognostic (1.66e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	"prognostic favourable (3.12e-5)"	"unprognostic (1.66e-2)"	"prognostic unfavourable (1.78e-5)"	"unprognostic (1.93e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.55e-2)"	5.0	6.8	5.1	4.2	12.0	0.3	3.3	0.3	4.3	17.5	28.1	1.6	10.2	5.4	25.7	5.9	16.3	11.7	26.0	2.2	2.5	2.1	4.7	5.5	3.5	0.7	1.0	2.8	31.8	2.1	6.6	14.8	1.9	2.0	21.0	2.2	4.2	1.7	24.9	2.9	4.8	8.5	49.5	1.1	0.5	9.7	11.7	2.1	0.0	5.2	1.4	0.5	34.6	20.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	10.8	1.8	15.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.0	6.4	0.0	0.0	6.5	1.9	0.0	2.8	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	28.6	0.0	0.0	5.8	2.2	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.5	8.5	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	12.0	0.3	4.3	2.5	2.1	1.0	2.8	2.0	2.1
CALD1	"CDM, H-CAD, L-CAD"	ENSG00000122786	"Caldesmon 1"	Q05682	7	134744252-134970728	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 224.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 78.6;fHDF/TERT166: 127.8;U-138 MG: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"neutrophil: 4.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000006, HPA008066, HPA017330"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		110000000	110000000	"Plasma membrane, Actin filaments"	"Plasma membrane, Actin filaments"	"CAB000006: AB_2065456, HPA008066: AB_1078378, HPA017330: AB_1845917"	"unprognostic (2.16e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (6.52e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	38.6	17.4	6.7	33.4	11.1	0.0	26.6	11.9	9.1	83.1	141.0	6.0	111.4	12.6	82.3	59.8	122.8	45.8	46.3	20.1	7.7	5.0	33.5	39.6	26.1	12.9	8.7	8.5	76.3	6.9	4.1	17.8	57.4	8.9	87.8	25.1	10.9	12.4	133.3	15.3	12.9	39.2	224.5	8.5	35.9	64.5	29.7	9.7	2.1	20.3	14.1	5.3	205.3	70.4	0.1	0.2	4.3	0.2	0.4	0.2	5.9	12.0	7.9	17.9	15.7	62.2	50.4	17.7	70.9	78.6	24.4	27.1	14.4	0.3	0.0	16.9	127.8	2.8	11.4	21.1	33.2	0.1	3.8	0.4	9.4	9.7	40.9	0.0	0.0	38.7	15.7	27.3	15.4	20.5	0.0	0.1	36.4	0.0	0.0	0.2	21.4	2.7	0.1	15.9	0.0	5.0	3.2	3.1	7.8	24.9	3.3	9.5	0.7	0.1	54.7	82.0	14.3	15.5	24.1	0.0	0.0	0.0	28.5	0.0	61.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	4.3	0.4	0.0	0.0	0.0	5.9	6.7	11.1	11.9	9.1	7.7	5.0	8.7	8.5	8.9	9.7
CASQ2	PDIB2	ENSG00000118729	"Calsequestrin 2"	O14958	1	115700007-115768781	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 172.4;skeletal muscle: 46.5;smooth muscle: 45.9"	"Cell line enriched"	"Detected in single"	20	"HSkMC: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.7"	"Region enriched"	"Detected in many"	5	"cerebellum: 48.4"	"Low region specificity"	"Detected in many"			"HPA027285, HPA055298"	Enhanced				"Intracellular and membrane"					"HPA027285: AB_1845933, HPA055298: AB_2682777"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.41e-2)"	"prognostic unfavourable (2.30e-4)"	"unprognostic (1.03e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavourable (2.25e-5)"	4.9	0.6	0.4	1.8	0.7	0.1	1.6	0.7	0.5	4.3	11.1	0.6	1.1	0.6	6.2	6.3	13.6	3.0	1.9	172.4	0.4	0.5	0.7	0.2	1.1	0.2	0.6	0.5	5.0	0.3	0.5	0.2	0.3	1.0	12.1	3.1	4.6	1.8	3.6	46.5	1.0	3.2	45.9	0.5	0.2	3.5	1.9	0.0	0.0	1.4	17.2	1.8	36.4	1.8	0.0	0.1	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.4	0.7	0.7	0.5	0.4	0.5	0.6	0.5	1.0	0.0
CCDC60	MGC39827	ENSG00000183273	"Coiled-coil domain containing 60"	Q8IWA6	12	119334712-119541047	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.0;fallopian tube: 21.1;smooth muscle: 17.5;testis: 25.7"	"Cell line enhanced"	"Detected in some"		"AF22: 1.0;BEWO: 1.8;HBEC3-KT: 2.4;HeLa: 1.7;RT4: 2.6;U-2 OS: 1.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	7	"pons and medulla: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (2.96e-1)"	"unprognostic (2.05e-2)"	"unprognostic (7.73e-3)"	"unprognostic (2.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.98e-3)"		"unprognostic (1.00e-1)"		"unprognostic (2.70e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.92e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.54e-1)"	0.1	0.0	1.8	0.6	3.3	0.0	0.0	0.0	0.1	6.9	2.1	5.2	3.6	0.2	1.4	4.9	2.8	21.1	0.2	0.1	2.4	2.6	0.1	0.1	3.2	0.1	0.1	0.0	5.3	0.1	0.0	0.1	0.6	22.0	5.4	5.7	8.9	3.5	2.1	0.2	0.2	0.2	17.5	0.4	0.1	0.4	25.7	0.3	0.0	0.1	0.4	2.6	10.8	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.3	0.0	0.1	2.4	2.6	0.1	0.0	22.0	0.3
CHRM2		ENSG00000181072	"Cholinergic receptor muscarinic 2"	P08172	7	136868669-137020255	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 25.5;heart muscle: 35.0;smooth muscle: 32.8"	"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 43.7"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.8"	"Region enhanced"	"Detected in many"		"pons and medulla: 15.7"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022338, HPA029795"	Approved									"CAB022338: , HPA029795: AB_10601357"			"unprognostic (3.51e-2)"	"unprognostic (3.73e-4)"	"unprognostic (5.77e-2)"			"unprognostic (1.78e-2)"		"unprognostic (1.97e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.69e-1)"		"unprognostic (1.43e-2)"	"unprognostic (1.80e-1)"		"unprognostic (1.35e-3)"	0.8	0.9	3.6	7.2	1.9	0.3	0.8	0.8	6.0	0.9	8.9	0.0	0.0	0.9	0.8	0.3	0.8	0.8	25.5	35.0	0.9	0.9	0.8	1.2	1.0	0.2	0.9	2.2	0.8	0.8	0.2	0.9	1.7	15.7	5.4	3.9	0.0	0.8	0.2	0.8	0.8	3.7	32.8	5.0	0.8	2.7	2.3	1.5	0.0	0.8	0.0	0.2	14.0	1.8	0.0	0.2	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	9.0	0.1	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	0.2	0.0	0.0	3.6	1.9	0.8	6.0	0.9	0.9	0.9	2.2	15.7	1.5
CLEC3A	CLECSF1	ENSG00000166509	"C-type lectin domain family 3 member A"		16	78022515-78066761	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"breast: 14.6;prostate: 8.6;smooth muscle: 17.1;urinary bladder: 17.2"	"Group enriched"	"Detected in some"	4	"SK-BR-3: 7.3;T-47d: 20.9"	"Cancer enriched"	"Detected in some"	102	"breast cancer: 78.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 0.5"	"Low region specificity"	"Detected in single"			HPA051511	Uncertain				"Secreted to extracellular matrix"					"HPA051511: AB_2681514"	"prognostic unfavourable (1.61e-4)"				"unprognostic (1.60e-1)"							"unprognostic (2.42e-1)"		"unprognostic (1.25e-1)"	"unprognostic (4.95e-2)"		"unprognostic (3.80e-2)"	0.1	0.1	0.1	1.8	0.3	0.0	14.6	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	4.6	0.3	0.1	1.1	0.1	0.1	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.4	8.6	0.0	3.3	0.1	0.0	0.1	0.1	0.1	17.1	0.1	0.1	0.8	0.1	0.0	0.0	0.1	1.9	0.0	17.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.8	0.1	1.1	0.1	0.0	0.4	0.0
CNN1	"Sm-Calp, SMCC"	ENSG00000130176	"Calponin 1"	P51911	19	11538717-11550323	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 489.2;urinary bladder: 357.9"	"Cell line enhanced"	"Detected in some"		"BJ: 34.6;BJ hTERT+: 13.3;BJ hTERT+ SV40 Large T+: 18.1;BJ hTERT+ SV40 Large T+ RasG12V: 25.1;HBF TERT88: 28.0;K-562: 12.9;U-2 OS: 13.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 142.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000007, HPA014263"	Enhanced		Approved	"Actin filaments"				"Actin filaments"	"Actin filaments"	"CAB000007: AB_2082148, HPA014263: AB_1847039"	"unprognostic (4.98e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (5.43e-6)"	"unprognostic (1.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.78e-3)"	"unprognostic (6.11e-3)"	9.3	4.1	0.5	34.9	0.9	0.0	7.9	0.5	1.2	90.5	193.4	1.3	78.1	9.4	182.6	50.6	140.5	52.2	105.7	22.2	0.6	0.6	6.2	1.0	9.5	2.2	0.7	1.8	36.5	1.3	0.0	0.7	4.0	2.2	120.1	26.4	8.8	9.1	125.2	4.8	4.5	37.1	489.2	1.0	1.2	66.5	16.4	0.5	0.4	3.2	4.5	3.3	357.9	26.8	0.0	0.4	0.0	0.1	0.0	0.0	5.2	0.0	0.5	2.2	0.4	0.2	0.0	1.4	34.6	13.3	18.1	25.1	9.8	0.0	0.1	1.0	9.8	0.1	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.1	1.2	0.0	11.1	0.0	0.0	12.9	0.0	0.0	0.0	0.1	1.7	1.1	0.2	0.1	0.4	1.3	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	13.0	0.5	0.4	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.5	0.9	0.5	1.2	0.6	0.6	0.7	1.8	2.2	0.5
CNTNAP1	"Caspr, CNTNAP, NRXN4, p190"	ENSG00000108797	"Contactin associated protein 1"	P78357	17	42682613-42699814	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.7;smooth muscle: 26.7"	"Cell line enhanced"	"Detected in many"		"TIME: 29.6;U-138 MG: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011772	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA011772: AB_1079541"	"unprognostic (4.04e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.76e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (4.16e-14)"	"unprognostic (9.52e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.37e-3)"	6.1	2.5	35.5	5.9	18.8	1.1	1.7	31.7	48.7	4.7	8.5	2.9	1.4	2.3	12.1	7.1	2.9	7.0	7.1	4.0	29.2	14.8	1.7	0.9	3.9	2.8	10.5	23.9	8.7	6.5	1.7	7.2	5.0	18.4	4.2	4.7	2.1	2.0	7.6	3.5	2.5	2.7	26.7	11.5	3.2	3.9	2.3	13.3	0.0	1.7	0.2	2.9	5.8	3.3	0.0	0.7	0.1	0.0	0.1	1.4	0.0	1.7	2.6	5.7	1.9	8.9	18.2	0.3	10.8	18.8	8.0	7.2	0.3	0.4	0.0	0.6	11.8	2.1	2.8	0.8	6.3	4.2	0.9	0.0	10.6	2.6	4.4	0.0	0.1	17.7	0.0	7.6	1.5	10.0	0.5	3.3	3.0	0.3	0.0	1.5	2.0	2.5	0.3	0.7	1.0	2.1	0.0	1.1	3.4	3.2	0.0	2.0	2.0	0.9	29.6	34.3	5.8	7.9	2.9	4.0	2.4	0.1	9.5	0.7	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	1.4	0.0	35.5	18.8	31.7	48.7	29.2	14.8	10.5	23.9	18.4	13.3
COL4A6		ENSG00000197565	"Collagen type IV alpha 6 chain"	Q14031	X	108155607-108439497	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 60.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 18.1;HeLa: 15.9;HHSteC: 24.4;hTERT-HME1: 17.9;HUVEC TERT2: 16.5;TIME: 36.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"							HPA065393			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"			"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA065393: AB_2685483"	"unprognostic (8.47e-3)"	"unprognostic (4.50e-3)"	"unprognostic (9.75e-3)"	"unprognostic (9.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.54e-3)"	"unprognostic (3.51e-1)"	2.1	0.4	0.4	0.8	0.5	0.0	1.7	0.2	0.4	12.1	1.0	1.3	8.0	0.7	22.9	17.1	25.0	11.3	35.8	3.6	0.6	0.6	3.0	0.3	2.1	0.0	1.0	0.9	6.4	0.3	7.6	11.3	1.9	0.9	16.5	1.3	8.3	1.4	15.6	1.0	4.1	1.8	60.9	1.4	1.1	10.4	2.1	0.7	0.2	0.6	1.4	0.5	24.7	6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.1	3.9	0.0	9.9	0.7	0.0	0.0	0.7	0.1	0.1	6.9	0.0	0.0	0.0	0.0	2.3	4.1	18.1	0.3	0.1	3.4	0.3	15.9	0.1	24.4	0.0	0.0	1.0	11.2	2.6	17.9	16.5	0.0	0.0	0.2	0.0	0.0	0.0	5.5	1.5	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.9	0.0	0.0	0.3	0.0	36.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.4	0.6	0.6	1.0	0.9	0.9	0.7
DES	"CMD1I, CSM1, CSM2"	ENSG00000175084	Desmin	P17661	2	219418377-219426739	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 531.0;skeletal muscle: 600.8;smooth muscle: 439.9"	"Cell line enhanced"	"Detected in some"		"HSkMC: 17.6;LHCN-M2: 35.2;RH-30: 81.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 562.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.7;intermediate monocyte: 1.9;non-classical monocyte: 1.4"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 45.7"	"CAB000034, HPA018803"	Enhanced		Supported	"Intermediate filaments"		1300000	1300000	"Intermediate filaments"	"Intermediate filaments"	"CAB000034: , HPA018803: AB_1847616"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.76e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.61e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavourable (5.08e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-3)"	9.1	2.5	0.1	35.1	0.2	0.1	1.9	0.1	0.3	41.3	238.3	0.4	69.1	12.6	95.6	80.2	209.7	33.0	149.8	531.0	0.1	0.1	2.1	0.3	4.8	3.0	0.3	0.8	20.3	0.7	0.0	0.1	2.4	0.8	101.0	11.2	3.8	11.9	104.2	600.8	4.2	43.2	439.9	0.3	0.6	72.6	10.9	0.0	0.0	9.4	161.2	12.5	343.7	34.4	0.0	0.2	0.4	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.3	17.6	0.0	0.0	0.0	0.0	0.6	0.0	35.2	0.0	0.0	9.2	0.1	0.0	0.0	81.8	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.7	0.1	0.2	0.1	0.3	0.1	0.1	0.3	0.8	0.8	0.0
DPYSL3	"CRMP4, DRP-3, ULIP"	ENSG00000113657	"Dihydropyrimidinase like 3"	Q14195	5	147390811-147510056	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 91.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 34.8;SH-SY5Y: 117.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010948	Approved		Supported	Cytosol		170000	170000	Cytosol	Cytosol	"HPA010948: AB_1847245"	"unprognostic (3.92e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (3.87e-9)"	"unprognostic (1.14e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (8.23e-4)"	21.7	7.2	22.9	18.9	20.4	0.5	14.1	6.7	31.0	26.8	39.7	20.9	31.4	6.8	38.8	28.0	28.8	20.1	33.9	18.5	23.7	24.7	2.5	1.8	16.2	6.1	16.7	15.2	33.0	2.2	1.0	4.2	7.1	27.0	40.0	14.3	32.3	7.1	61.4	22.1	7.3	12.9	91.4	24.7	9.1	15.0	12.1	15.9	0.3	7.2	15.5	9.6	45.6	18.9	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	6.0	10.9	0.0	0.4	11.1	0.2	5.7	27.4	12.2	16.3	18.8	0.5	0.0	1.6	16.6	0.6	2.2	0.2	13.7	2.6	4.9	0.0	5.2	0.0	11.0	0.0	0.0	2.1	0.1	26.3	10.4	34.8	0.0	0.2	6.9	0.0	0.0	0.1	23.1	9.0	0.0	23.1	0.0	10.7	2.3	8.0	117.8	0.0	0.0	1.8	0.0	0.1	15.2	8.9	6.7	21.6	21.0	19.5	3.4	0.0	8.2	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	22.9	20.4	6.7	12.5	23.7	24.7	16.7	15.2	27.0	15.9
EPPK1	EPIPL1	ENSG00000261150	"Epiplakin 1"		8	143857324-143878464	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"salivary gland: 14.8;skin 1: 14.1;smooth muscle: 15.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 10.9;EFO-21: 10.2;HaCaT: 10.1;HeLa: 16.9;MCF7: 14.6;SK-BR-3: 7.0"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA066808, HPA067357, HPA069333"	Approved		Enhanced	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"HPA066808: AB_2685726, HPA067357: AB_2685826, HPA069333: AB_2686123"	"unprognostic (1.42e-1)"	"unprognostic (9.30e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavourable (5.52e-5)"	"unprognostic (2.85e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.90e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.97e-3)"	"unprognostic (5.94e-3)"	"unprognostic (4.35e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.08e-3)"	0.0	0.0	0.0	3.0	0.0	0.0	1.1	0.7	0.0	0.4	7.8	0.0	7.2	3.1	3.4	2.4	6.0	1.4	2.3	0.0	0.0		0.8	0.0	4.2	0.9	0.0	0.0	1.0	1.9	0.6	0.0	2.8	0.5	2.9	0.8	0.0	14.8	4.9	0.1	14.1	12.1	15.7	0.1	1.5	1.2	2.3	0.0	0.0	0.0	7.2	4.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	5.4	0.4	0.0	10.2	0.0	10.1	1.0	0.1	0.0	0.0	2.6	0.0	16.9	3.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	14.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	3.6	1.7	0.0	1.6	7.0	0.0	5.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	1.0	0.2	0.0	0.0	2.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0										
FAM129A	"C1orf24, GIG39, NIBAN"	ENSG00000135842	"Family with sequence similarity 129 member A"	Q9BZQ8	1	184790724-184974550	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 129.1;urinary bladder: 90.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 32.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 32.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA028172, HPA028231, HPA028657"	Approved		Supported	"Plasma membrane,Cytosol"		40000	40000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA028172: AB_10599602, HPA028231: AB_10601886, HPA028657: AB_10601680"	"unprognostic (4.61e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.64e-3)"	"unprognostic (9.46e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.94e-3)"	"unprognostic (9.01e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.73e-2)"	"prognostic unfavourable (4.52e-4)"	10.1	3.5	1.1	16.9	1.8	2.3	7.8	0.8	1.3	13.0	39.3	1.0	14.9	2.5	14.6	11.0	32.3	10.7	30.4	52.2	1.1	1.1	1.8	1.2	6.1	10.7	3.0	0.5	8.0	27.3	0.8	1.9	2.9	1.7	34.6	5.1	13.8	59.3	14.7	21.4	4.1	8.3	129.1	2.1	6.5	30.0	4.1	1.3	4.9	4.7	14.7	8.7	90.3	20.3	0.5	2.3	32.7	1.5	2.6	5.3	0.8	13.6	0.1	0.0	0.0	9.8	14.9	0.5	7.0	14.4	6.1	7.7	0.0	5.8	0.0	4.6	18.0	15.4	0.8	0.5	9.8	27.2	1.1	5.7	2.9	0.0	22.8	18.5	6.5	13.6	22.3	17.7	21.5	0.0	1.3	28.9	0.1	0.0	0.6	3.2	3.7	1.4	4.3	3.3	0.2	8.4	0.2	0.7	0.7	0.1	0.0	10.0	3.0	5.9	1.1	12.1	0.0	2.1	14.4	24.3	9.6	2.9	23.7	7.7	11.8	7.1	1.5	4.7	2.5	0.9	2.1	0.5	2.2	2.3	2.3	0.1	0.2	0.9	32.7	2.6	0.3	0.2	5.3	0.8	1.1	1.8	0.8	1.3	1.1	1.1	3.0	0.5	1.7	1.3
FAM83D	"C20orf129, CHICA, dJ616B8.3"	ENSG00000101447	"Family with sequence similarity 83 member D"	Q9H4H8	20	38926312-38953106	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 39.0;smooth muscle: 69.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 1.6;NK-cells: 2.4;T-cells: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049333, HPA060854"			Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol"				"Mitotic spindle"	"Mitotic spindle"	"HPA049333: AB_2680717, HPA060854: "	"unprognostic (7.90e-3)"	"unprognostic (4.34e-2)"	"unprognostic (6.41e-2)"	"prognostic unfavourable (1.49e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (5.44e-6)"	"prognostic unfavourable (9.69e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (4.73e-5)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (1.81e-14)"	"unprognostic (2.57e-3)"	"unprognostic (5.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.87e-2)"	0.5	0.5	0.5	4.9	0.8	7.9	0.7	0.4	1.2	1.7	29.6	0.4	0.7	3.4	0.8	1.5	39.0	0.2	5.6	1.5	0.5	0.1	2.2	1.4	2.6	1.5	0.3	0.5	0.7	0.2	0.0	0.3	2.2	0.7	7.6	3.6	1.2	3.1	1.0	0.4	4.1	16.2	69.8	0.4	1.0	22.8	3.8	0.2	9.2	0.5	8.6	17.9	24.5	6.4	1.6	0.1	0.0	0.4	2.4	4.6	1.2	31.2	19.3	15.3	12.8	1.7	1.9	27.4	14.1	8.8	27.9	17.1	29.4	14.4	7.9	14.0	9.2	26.9	20.8	24.1	26.2	2.6	8.2	9.2	14.8	21.2	1.4	4.0	4.8	1.0	1.2	16.0	9.3	15.3	8.1	11.5	15.8	16.8	6.2	5.9	12.6	24.6	6.0	28.1	4.4	8.0	8.0	7.1	11.8	41.1	34.3	6.1	21.4	4.2	7.3	18.5	22.7	21.0	30.9	3.5	5.3	8.2	8.3	6.0	13.5	0.0	0.0	0.0	0.7	0.4	2.3	1.6	2.4	2.7	0.1	1.6	2.7	3.4	0.0	2.4	0.1	0.0	4.6	1.2	0.5	0.8	0.4	1.2	0.5	0.1	0.3	0.5	0.7	0.2
FBXL22	"Fbl22, FLJ39626"	ENSG00000197361	"F-box and leucine rich repeat protein 22"	Q6P050	15	63597353-63602428	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 65.9;smooth muscle: 68.0"	"Cell line enhanced"	"Detected in many"		"MCF7: 7.9;SCLC-21H: 9.0;U-937: 5.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA047624, HPA054627"	Uncertain		Uncertain	Nucleoli,Cytosol				"Nucleoli, Cytosol"	"Nucleoli, Cytosol"	"HPA047624: AB_2680107, HPA054627: AB_2682548"	"unprognostic (2.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	1.9	0.4	0.4	5.5	0.4	0.0	1.1	0.6	0.7	31.4	26.0	0.0	20.8	1.4	65.9	7.6	11.9	10.5	31.1	10.3	0.4	0.4	0.6	0.4	0.7	0.2	0.4	0.3	7.1	0.4	0.0	0.4	1.0	0.2	20.1	2.9	1.9	3.3	24.0	2.2	0.7	4.1	68.0	0.4	0.4	6.3	4.2	0.0	0.0	0.6	1.0	0.4	38.2	4.8	1.5	4.3	0.5	0.2	2.0	2.9	0.5	1.2	2.1	0.3	1.3	0.7	0.9	0.1	0.4	0.1	0.5	0.0	1.4	1.6	0.5	1.1	0.2	1.3	0.7	0.4	0.0	1.3	0.9	0.4	1.5	3.5	0.2	0.5	0.2	0.5	0.3	0.1	0.7	0.2	0.0	1.9	0.0	7.9	1.2	1.0	2.5	0.8	1.1	0.0	3.8	0.3	0.4	9.0	0.3	1.0	1.8	0.3	3.2	0.9	1.3	0.6	1.7	0.8	0.4	1.2	2.0	1.3	0.9	5.6	1.3	0.4	0.1	0.0	1.2	0.1	1.6	1.5	1.3	1.4	0.0	1.2	2.9	1.0	0.5	2.0	0.2	4.3	0.1	0.5	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.3	0.2	0.0
FILIP1	"FILIP, KIAA1275"	ENSG00000118407	"Filamin A interacting protein 1"	Q7Z7B0	6	75291859-75493738	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 37.6;smooth muscle: 44.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 10.5;HUVEC TERT2: 2.6;RPTEC TERT1: 2.9;U-266/70: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA053564	Enhanced		Approved	"Plasma membrane,Actin filaments"				"Plasma membrane, Actin filaments"	"Plasma membrane, Actin filaments"	"HPA053564: AB_2682192"	"unprognostic (4.90e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.77e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.98e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.97e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.65e-2)"	"unprognostic (7.66e-3)"	11.0	1.3	2.0	6.3	3.0	0.2	2.5	0.6	2.5	8.2	10.9	0.0	4.1	1.3	8.8	4.1	10.5	4.5	5.9	37.6	3.7	1.2	2.7	2.4	7.5	1.2	1.1	0.7	4.4	1.4	5.4	5.1	3.7	0.8	14.9	2.6	4.3	1.5	2.8	29.4	0.9	4.1	44.7	1.4	0.6	3.9	2.8	0.0	0.0	2.3	10.8	0.7	30.7	6.0	1.4	0.9	1.8	0.8	0.6	0.9	0.0	0.1	1.9	0.3	0.1	0.1	0.3	0.2	0.3	0.1	0.1	0.0	0.0	0.2	0.2	10.5	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.2	0.2	0.1	0.0	0.2	0.2	1.4	0.1	0.2	0.0	2.6	0.1	0.4	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	2.9	0.6	0.2	0.2	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.0	0.1	0.1	10.4	1.0	0.1	0.1	0.5	0.1	1.2	0.6	0.6	0.6	0.6	0.5	0.6	0.5	0.4	0.2	1.4	0.9	0.6	1.8	0.6	0.8	0.9	0.3	0.0	2.0	3.0	0.6	1.9	3.7	1.2	1.1	0.7	0.8	0.0
FLNA	"ABP-280, FLN, FLN1, OPD1, OPD2"	ENSG00000196924	"Filamin A"	P21333	X	154348524-154374638	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 396.7;urinary bladder: 276.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB000356, HPA000368, HPA001016, HPA001115, HPA002925"	Enhanced	Approved	Enhanced	"Plasma membrane,Actin filaments,Cytosol"		2900000000	2900000000	"Plasma membrane, Actin filaments, Cytosol"	"Plasma membrane, Actin filaments, Cytosol"	"CAB000356: , HPA000368: AB_2797215, HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869"	"unprognostic (1.39e-1)"	"unprognostic (9.40e-3)"	"prognostic unfavourable (7.37e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavourable (1.54e-6)"	"unprognostic (5.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (3.88e-4)"	42.8	8.8	2.9	46.4	3.9	22.9	30.7	2.0	5.2	106.5	204.2	6.3	86.0	13.1	158.9	54.4	140.2	79.9	121.0	18.8	3.2	2.2	17.2	5.5	29.1	21.1	3.4	5.9	77.4	7.3	1.6	4.8	20.0	9.4	129.3	13.4	19.0	12.6	98.8	13.7	15.0	50.2	396.7	3.6	25.5	82.7	29.9	2.9	12.1	11.7	16.3	15.1	276.1	64.5	6.3	13.1	7.1	19.7	5.9	22.6	24.1	87.2	67.8	23.9	30.8	20.9	27.7	39.4	58.4	65.1	53.6	47.7	43.9	16.2	7.5	151.6	90.7	50.1	21.5	51.2	15.1	30.8	7.5	24.2	88.7	15.2	38.5	28.6	31.8	26.5	12.4	79.8	31.9	39.8	6.8	52.3	38.3	20.0	13.6	9.9	25.2	45.1	13.7	21.7	6.7	20.8	18.2	5.3	12.1	48.8	7.9	39.3	7.6	9.0	95.2	61.2	59.0	62.0	107.6	32.8	19.2	15.2	56.9	19.2	61.2	4.1	11.5	7.1	22.6	15.2	14.3	6.3	10.5	18.7	13.1	3.0	4.0	9.1	2.6	5.9	19.7	1.7	12.8	24.1	2.9	3.9	2.0	5.2	3.2	2.2	3.4	5.9	9.4	2.9
FOXF1	"FKHL5, FREAC1"	ENSG00000103241	"Forkhead box F1"	Q12946	16	86510527-86515418	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 54.7;urinary bladder: 48.5"	"Group enriched"	"Detected in some"	4	"BJ: 9.2;BJ hTERT+: 20.2;HHSteC: 19.9;U-2197: 8.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA028886			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA028886: AB_10601652"	"unprognostic (7.91e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.62e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.22e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.20e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.44e-1)"	2.2	0.3	2.5	15.4	2.9	0.0	0.8	2.3	4.2	7.9	34.6	1.3	1.6	7.2	2.1	0.9	17.9	1.2	39.7	0.6	3.4	1.9	1.2	2.4	33.1	2.4	3.5	1.0	0.6	0.9	1.1	0.4	18.5	3.5	35.7	9.2	0.5	0.9	4.8	0.3	0.4	18.4	54.7	3.0	0.5	18.4	0.6	3.7	0.0	3.6	2.6	3.3	48.5	25.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	20.2	2.8	0.9	0.0	0.1	0.0	0.0	0.8	0.0	1.6	0.0	2.4	0.0	1.1	0.0	1.4	0.0	19.9	0.0	1.7	2.1	0.0	3.3	0.4	3.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	3.0	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	8.7	0.0	0.0	0.0	0.0	1.8	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.5	2.9	2.3	4.2	3.4	1.9	3.5	1.0	3.5	3.7
FOXP2	"CAGH44, SPCH1, TNRC10"	ENSG00000128573	"Forkhead box P2"	O15409	7	114086327-114693772	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 48.4;urinary bladder: 31.5"	"Cell line enhanced"	"Detected in many"		"AF22: 14.7;RH-30: 27.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000382, HPA000383, HPA001679"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA000382: AB_1078908, HPA000383: AB_1078909, HPA001679: AB_2666415"	"unprognostic (1.21e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.83e-3)"	"unprognostic (4.66e-1)"	"unprognostic (3.69e-4)"	"unprognostic (2.04e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.04e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.84e-1)"	"unprognostic (9.81e-2)"	"unprognostic (4.19e-2)"	1.7	1.5	0.9	9.4	2.9	0.0	2.0	0.6	2.8	9.4	20.4	0.7	3.6	2.7	18.1	2.1	12.4	3.5	7.7	1.2	0.7	2.9	1.5	2.9	1.4	0.6	2.0	1.0	11.1	4.5	0.0	0.9	0.7	1.8	13.3	5.7	1.4	2.8	1.5	4.6	3.3	4.2	48.4	0.9	0.6	4.6	0.9	0.9	0.6	5.3	3.2	1.2	31.5	5.4	9.4	16.5	11.1	7.2	6.3	10.3	16.3	0.2	2.1	14.7	0.0	3.4	4.6	0.9	2.3	2.5	0.5	0.3	1.0	0.2	0.2	0.5	0.8	0.3	0.5	0.0	0.1	0.1	5.0	5.5	3.3	4.5	0.0	0.3	0.3	1.1	0.6	0.0	0.0	0.6	1.2	2.1	0.5	1.0	1.2	0.8	0.7	0.7	0.3	27.0	5.2	0.3	5.9	3.8	1.5	0.0	0.9	0.7	0.7	8.0	1.1	0.9	0.4	1.4	0.4	5.3	0.4	0.5	1.1	0.5	0.4	7.5	5.2	11.1	6.2	7.2	6.3	9.4	7.0	6.8	6.8	7.3	7.2	8.1	5.6	6.3	5.9	16.5	10.3	16.3	0.9	2.9	0.6	2.7	0.7	2.9	2.0	1.0	1.8	0.9
GCOM1	"FLJ30973, GRINL1A, MYZAP-POLR2M"	ENSG00000137878	"GRINL1A complex locus 1"		15	57591908-57714745	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"heart muscle: 107.1;smooth muscle: 42.3"	"Cell line enhanced"	"Detected in some"		"HEL: 24.8;RH-30: 7.0;RT4: 7.8;TIME: 10.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"cerebellum: 10.4;pons and medulla: 3.9"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.6;naive CD4 T-cell: 4.0"	"Group enriched"	"Detected in many"	5	"B-cells: 3.6;monocytes: 1.5;T-cells: 4.0"									"HPA039827, HPA068141"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA039827: AB_10673364, HPA068141: AB_2685962"	"unprognostic (1.10e-1)"	"unprognostic (3.62e-4)"	"unprognostic (1.10e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.69e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.03e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.78e-2)"	6.7	4.6	1.2	1.9	1.4	2.9	10.3	10.4	1.3	4.1	3.6	0.1	2.3	3.6	5.2	1.2	9.9	1.3	2.3	107.1	1.2	1.6	1.2	0.9	7.6	1.7	1.2	0.0	2.3	5.6	0.4	1.0	9.1	3.9	10.2	1.3	0.0	4.6	2.7	7.3	2.6	5.8	42.3	1.0	2.6	3.3	2.5	0.0	0.0	1.1	5.0	4.8	25.3	9.5	3.6	0.5	0.4	1.5	0.0	4.0	4.5	3.2	0.6	0.0	3.2	0.0	0.0	0.8	0.6	2.2	1.0	1.0	2.3	3.2	0.0	0.5	0.0	2.1	0.0	1.9	0.9	0.0	0.1	24.8	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.3	4.9	1.0	1.3	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.0	7.0	0.0	0.0	7.8	0.0	0.8	0.7	0.7	0.0	3.1	0.0	10.7	0.3	2.0	0.3	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	1.2	0.7	0.0	0.5	3.6	4.0	0.0	0.4	0.0	1.5	0.0	0.3	4.5	1.2	1.4	10.4	1.3	1.2	1.6	1.2	0.0	3.9	0.0
GLRA4		ENSG00000188828	"Glycine receptor alpha 4"	Q5JXX5	X	103707224-103728655	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 3.5;endometrium 1: 5.1;smooth muscle: 6.7"	"Cell line enriched"	"Detected in single"	13	"SCLC-21H: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA044759	Uncertain									"HPA044759: AB_10795885"	"unprognostic (4.96e-2)"		"unprognostic (2.09e-2)"		"unprognostic (3.95e-1)"	"unprognostic (2.24e-1)"			"unprognostic (1.28e-1)"		"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.94e-7)"	"unprognostic (4.49e-1)"	"unprognostic (1.94e-1)"		"unprognostic (1.87e-1)"	0.0	0.0	0.9	0.1	1.5	0.0	0.3	2.8	3.5	1.9	1.4	0.9	0.0	2.2	5.1	0.1	0.2	0.6	0.1	0.1	1.5	1.8	0.0	0.0	0.0	0.0	0.5	1.0	1.2	0.0	2.4	0.2	0.0	1.2	0.5	1.8	0.0	0.0	0.4	0.1	0.3	2.3	6.7	1.5	0.0	0.1	1.4	0.0	2.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.5	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	1.5	2.8	3.5	1.5	1.8	0.5	1.0	1.2	0.0
GPR161	RE2	ENSG00000143147	"G protein-coupled receptor 161"	Q8N6U8	1	168079543-168137667	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 27.1;smooth muscle: 21.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 23.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015576, HPA072047"	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoplasm	"HPA015576: AB_1849283, HPA072047: AB_2686484"	"unprognostic (1.45e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.57e-6)"	"unprognostic (3.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	2.4	0.9	2.1	3.6	1.7	0.0	1.9	1.2	4.0	7.3	4.9	3.1	8.5	0.8	27.1	8.2	7.4	7.7	5.6	2.4	2.8	1.5	1.1	0.4	2.8	0.4	3.0	1.2	7.6	11.0	4.9	1.3	1.3	3.0	8.2	2.3	3.4	2.3	9.4	0.8	1.5	2.1	21.0	3.0	1.2	2.2	3.0	0.8	1.4	1.2	1.7	0.7	2.8	6.8	0.3	1.2	1.5	0.5	0.2	0.3	0.2	6.1	3.8	15.3	9.8	3.7	6.6	0.0	5.9	6.4	5.0	5.4	23.8	1.0	0.0	3.3	8.8	18.2	3.7	5.8	2.9	2.3	4.7	2.2	3.0	0.1	1.5	0.6	1.5	2.3	3.7	4.3	7.0	10.1	2.0	0.1	7.6	0.5	0.7	0.1	6.3	6.0	1.8	6.6	0.0	2.6	1.6	3.1	13.5	6.4	0.2	17.6	3.4	0.7	13.5	10.5	5.4	14.0	6.6	0.0	0.0	0.0	2.8	0.0	2.6	1.5	0.3	0.2	0.1	0.3	0.1	0.1	0.1	0.0	1.2	0.3	0.1	0.3	1.3	0.2	0.5	0.3	0.0	0.2	2.1	1.7	1.2	4.0	2.8	1.5	3.0	1.2	3.0	0.8
GREM1	"CKTSF1B1, CRAC1, DAND2, DRM, gremlin, HMPS"	ENSG00000166923	"Gremlin 1, DAN family BMP antagonist"	O60565	15	32717974-32745107	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 66.8;smooth muscle: 42.5"	"Cell line enhanced"	"Detected in some"		"BJ: 32.0;BJ hTERT+: 49.1;BJ hTERT+ SV40 Large T+ RasG12V: 30.8;fHDF/TERT166: 98.6;hTEC/SVTERT24-B: 30.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 24.6"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 3.6;olfactory region: 13.4"	"Low region specificity"	"Detected in many"			HPA007526	Uncertain				"Secreted to blood"					"HPA007526: AB_1849971"	"unprognostic (4.74e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (4.46e-4)"	"unprognostic (5.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.20e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.13e-11)"	"unprognostic (1.77e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.16e-3)"	14.9	1.2	3.1	23.1	10.2	1.1	11.7	0.8	5.6	31.3	15.2	6.6	1.1	2.6	5.1	1.0	15.4	1.0	66.8	1.1	4.4	2.0	1.2	1.5	1.2	8.0	6.6	6.4	1.0	1.5	1.0	0.2	1.1	5.5	6.4	15.2	0.0	1.0	5.1	2.4	4.1	24.4	42.5	4.8	1.3	23.7	1.1	9.3	0.0	1.4	2.2	2.3	27.3	32.2	0.4	0.5	1.4	0.4	0.7	0.3	0.0	0.0	0.5	0.0	0.0	1.2	1.7	0.0	32.0	49.1	12.1	30.8	0.0	0.0	0.0	0.0	98.6	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	30.9	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	0.1	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.2	0.4	0.5	0.3	0.2	0.3	0.3	0.3	0.2	0.1	0.4	0.3	0.3	1.4	0.7	0.4	0.5	0.2	0.0	3.1	10.2	0.8	5.6	4.4	2.0	6.6	6.4	5.5	9.3
HAND1	"bHLHa27, eHand, Hxt, Thing1"	ENSG00000113196	"Heart and neural crest derivatives expressed 1"	O96004	5	154474972-154478264	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 25.9;intestine: 35.1;smooth muscle: 14.2"	"Cell line enriched"	"Detected in some"	7	"SH-SY5Y: 50.8"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 0.6;testis cancer: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040925	Approved		Uncertain	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	Nucleoplasm	"HPA040925: AB_10796563"			"unprognostic (2.37e-2)"					"unprognostic (8.29e-2)"		"unprognostic (2.46e-3)"	"unprognostic (7.23e-2)"				"unprognostic (5.21e-2)"		"unprognostic (6.38e-3)"	0.2	6.0	0.1	9.7	0.1	0.0	0.1	0.1	0.1	0.1	35.1	0.0	0.0	4.4	0.1	0.0	0.1	0.1	5.3	25.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	3.6	0.0	5.4	2.6	0.1	0.1	0.0	0.1	0.1	20.8	14.2	0.1	0.1	0.1	0.2	0.0	0.7	0.1	0.0	0.0	9.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	50.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
HOXA11	"HOX1, HOX1I"	ENSG00000005073	"Homeobox A11"	P31270	7	27181510-27185223	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 35.7;endometrium 1: 60.9;smooth muscle: 27.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.5;HEK 293: 24.6;THP-1: 17.6;U-937: 22.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006770, HPA035623"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA006770: AB_2667672, HPA035623: AB_10601576"	"unprognostic (5.95e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.29e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.82e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavourable (2.57e-5)"	"unprognostic (2.17e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.56e-1)"	1.5	0.4	0.0	1.7	0.0	0.0	2.0	0.0	0.0	35.7	9.3	0.0	5.7	0.0	60.9	8.8	0.0	0.7	0.0	0.2	0.0	0.0	3.6	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	9.0	0.0	16.5	2.4	0.0	0.1	6.3	4.9	0.7	0.2	27.3	0.0	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	20.1	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	0.1	0.0	6.7	8.2	5.8	0.0	14.5	17.5	10.3	7.4	0.1	0.8	0.0	3.3	12.2	1.6	8.6	0.0	7.5	0.8	24.6	3.0	6.0	0.3	0.5	6.1	0.8	3.7	0.3	0.0	0.0	7.4	0.1	0.0	1.1	0.1	0.0	4.7	0.0	7.2	0.3	0.0	0.1	4.9	4.2	3.2	0.0	3.5	0.0	1.0	0.6	17.6	0.0	0.1	7.1	1.6	0.7	0.0	0.0	0.0	0.1	22.9	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HPSE2	"HPA2, HPR2, UFS"	ENSG00000172987	"Heparanase 2 (inactive)"	Q8WWQ2	10	98457077-99235862	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 31.0;smooth muscle: 22.2"	"Group enriched"	"Detected in some"	19	"BJ hTERT+: 12.0;HEL: 22.5"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 4.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.3;T-reg: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA044603	Uncertain				"Secreted to extracellular matrix"					"HPA044603: AB_10794051"	"unprognostic (2.44e-1)"	"unprognostic (4.28e-3)"	"unprognostic (4.83e-3)"	"unprognostic (6.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.82e-2)"	"unprognostic (4.03e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.86e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.39e-3)"	"unprognostic (6.13e-3)"	1.6	0.1	2.0	4.1	9.7	0.1	5.5	2.7	4.2	31.0	3.1	5.4	0.9	3.4	8.0	0.2	17.2	2.3	2.1	0.1	1.7	8.3	1.4	0.1	2.4	0.1	12.2	1.4	0.2	0.1	0.1	0.2	1.7	12.4	12.1	3.2	0.4	1.0	4.9	0.2	1.4	5.1	22.2	11.9	0.1	2.5	2.2	7.6	0.0	0.2	0.2	0.4	12.4	12.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	12.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	22.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.6	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	2.0	9.7	2.7	3.1	1.7	8.3	12.2	1.4	12.4	7.6
HSPG2	"perlecan, PRCAN, SJS1"	ENSG00000142798	"Heparan sulfate proteoglycan 2"	P98160	1	21822245-21937297	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 104.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 45.8;HUVEC TERT2: 101.1;TIME: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009820, HPA018892, CAB020718"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	1700000000	1700000000	"Nucleoplasm, Plasma membrane, Cytosol"	"Nucleoplasm, Plasma membrane, Cytosol"	"CAB009820: AB_2119229, CAB020718: , HPA018892: "	"unprognostic (1.61e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavourable (2.82e-4)"	54.8	12.8	1.1	22.9	1.5	0.2	19.8	0.8	1.5	37.3	32.3	2.4	37.2	6.2	62.8	37.6	32.7	20.6	60.0	30.2	1.2	1.2	15.7	8.9	12.5	7.8	2.5	1.2	19.8	9.4	4.6	3.4	24.6	3.8	32.0	2.5	24.6	15.5	22.3	20.8	12.2	13.7	104.4	1.8	16.4	18.9	11.4	0.7	3.4	16.9	20.1	8.5	66.2	28.2	0.2	3.0	0.0	0.0	0.0	0.2	0.0	6.8	6.4	2.1	7.5	22.1	16.8	8.5	10.4	2.7	3.0	2.8	7.7	14.1	0.5	45.8	16.1	4.3	0.5	5.1	0.7	0.1	0.7	2.3	6.8	5.6	4.6	0.0	0.6	10.1	1.5	3.1	0.9	101.1	3.1	0.9	4.1	1.9	0.0	3.1	1.9	2.9	1.0	9.0	0.9	5.8	0.9	0.2	0.6	7.9	3.3	4.6	1.3	1.1	80.7	6.0	7.8	4.6	0.3	0.0	1.0	0.3	1.5	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	3.0	0.0	0.0	1.1	1.5	0.8	1.5	1.2	1.2	2.5	1.2	3.8	0.7
ITGA11	HsT18964	ENSG00000137809	"Integrin subunit alpha 11"	Q9UKX5	15	68296533-68432162	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 41.9;endometrium 1: 59.6;smooth muscle: 30.2"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 66.9;U-138 MG: 46.5;WM-115: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"basal ganglia: 6.1"	HPA051813	Uncertain					42000	42000			"HPA051813: AB_2681622"	"unprognostic (4.85e-2)"	"unprognostic (3.51e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.29e-3)"	"unprognostic (6.63e-2)"	"unprognostic (5.68e-3)"	"unprognostic (3.36e-1)"	"prognostic unfavourable (3.22e-7)"	"unprognostic (8.38e-3)"	"unprognostic (2.28e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.33e-2)"	4.5	2.9	0.4	3.5	0.9	0.0	2.9	0.5	3.6	41.9	1.5	0.9	3.5	0.6	59.6	11.4	2.6	8.0	3.4	9.0	0.5	0.5	4.9	0.7	1.3	0.5	0.8	0.5	15.7	0.8	0.2	1.5	2.2	1.3	4.5	1.4	1.5	0.9	8.9	1.9	2.1	1.6	30.2	0.9	4.0	1.3	3.4	0.7	0.2	1.8	5.8	0.7	5.6	7.4	1.7	1.3	1.8	1.0	0.8	1.5	0.1	0.0	0.0	0.1	0.2	2.2	0.0	0.0	4.4	8.6	1.0	0.3	0.0	0.0	0.0	0.3	66.9	0.0	0.0	0.0	0.2	0.0	0.0	0.1	3.6	0.0	5.9	0.0	3.7	0.8	0.0	1.9	0.1	0.0	0.0	0.0	11.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.1	2.7	46.5	0.3	0.9	0.0	0.0	0.0	0.0	6.9	0.0	25.8	1.6	1.0	0.9	1.2	0.9	1.5	0.8	1.1	1.0	0.7	1.7	1.3	1.2	1.8	0.8	0.8	1.3	1.0	0.1	0.4	0.9	0.5	3.6	0.5	0.5	0.8	0.5	1.3	0.7
ITGA5	"CD49e, FNRA"	ENSG00000161638	"Integrin subunit alpha 5"	P08648	12	54395261-54419460	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 137.7"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 140.8;TIME: 134.1;U-87 MG: 66.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 31.5"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"basal ganglia: 9.3"	"Low region specificity"	"Detected in some"			"HPA002642, CAB009008"	Enhanced					23000000	23000000			"CAB009008: AB_647474, HPA002642: AB_1078469"	"unprognostic (7.51e-3)"	"prognostic unfavourable (4.07e-6)"	"prognostic unfavourable (8.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (8.51e-3)"	"prognostic unfavourable (2.91e-4)"	"prognostic unfavourable (2.23e-5)"	"prognostic unfavourable (2.44e-4)"	"unprognostic (2.76e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.99e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavourable (1.32e-8)"	"unprognostic (2.11e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavourable (8.89e-4)"	"unprognostic (2.18e-3)"	23.3	7.9	2.1	32.2	2.8	9.2	30.5	1.2	2.2	16.0	66.9	2.2	19.0	3.4	19.3	13.8	18.2	12.0	12.4	20.3	2.9	0.8	4.6	15.2	20.4	9.2	3.2	1.2	13.6	5.3	3.7	1.8	57.7	3.3	26.6	10.2	4.9	4.4	28.9	10.0	8.8	14.9	137.7	3.5	3.1	19.7	6.6	2.5	3.0	7.3	5.8	4.5	82.1	20.6	0.1	22.2	31.5	22.9	9.1	5.6	12.4	6.6	2.4	4.6	0.0	14.3	30.5	12.0	30.0	31.2	30.9	22.8	1.6	1.5	0.0	21.9	31.3	1.0	1.2	8.3	21.4	0.0	1.2	2.9	3.3	0.1	19.8	9.0	4.6	22.0	4.1	36.2	27.9	140.8	2.4	0.0	17.5	0.6	1.3	10.1	1.8	1.9	1.4	3.1	0.6	4.9	0.1	0.0	0.0	6.0	0.4	0.2	0.7	8.1	134.1	37.6	6.7	9.2	12.4	0.0	0.3	0.0	66.9	8.6	12.2	5.6	22.9	0.1	5.6	10.0	4.4	0.0	4.2	4.2	22.2	0.1	3.1	2.6	31.5	9.1	7.6	1.2	1.7	12.4	2.1	2.8	1.2	2.2	2.9	0.8	3.2	1.2	3.3	2.5
ITGB1BP2	CHORDC3	ENSG00000147166	"Integrin subunit beta 1 binding protein 2"	Q9UKP3	X	71301734-71305371	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 43.0;skeletal muscle: 21.3;smooth muscle: 18.6;tongue: 19.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 13.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA040721			Approved	Cytosol				Cytosol	Cytosol	"HPA040721: "	"unprognostic (1.87e-1)"	"unprognostic (2.65e-2)"	"unprognostic (6.91e-5)"	"unprognostic (1.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.08e-11)"	"unprognostic (4.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-1)"	0.7	0.3	0.2	1.0	0.3	0.6	0.3	0.6	0.2	2.7	2.8	0.0	2.3	0.4	12.8	3.4	4.0	1.8	4.8	43.0	0.2	0.2	0.4	0.6	0.5	0.5	0.3	0.0	2.4	0.3	0.0	0.3	0.2	0.2	3.2	0.9	3.5	0.7	5.8	21.3	0.3	1.0	18.6	0.3	0.6	1.1	1.6	0.1	0.0	0.4	19.6	0.7	5.6	0.8	0.2	0.2	1.5	0.2	0.0	0.5	0.0	0.7	2.1	3.1	2.8	0.1	0.1	0.7	1.0	1.4	0.7	0.8	1.6	1.6	3.1	0.3	1.6	1.5	2.8	0.8	1.7	1.0	1.3	1.9	1.9	0.6	0.4	0.6	13.7	1.7	1.2	0.5	0.4	1.2	1.4	0.8	1.6	0.9	1.2	3.4	4.6	1.3	2.0	2.5	1.1	1.5	2.0	1.5	0.5	0.7	0.1	0.8	0.9	0.4	0.0	1.4	2.7	0.3	0.5	2.9	3.7	4.7	0.4	2.4	0.6	0.0	0.2	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.2	0.2	0.2	0.3	0.0	0.2	0.1
JPH2	JP-2	ENSG00000149596	"Junctophilin 2"	Q9BR39	20	44111695-44187578	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 72.6;smooth muscle: 55.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 12.8;EFO-21: 16.1;fHDF/TERT166: 16.2;HeLa: 10.6;SiHa: 10.8;T-47d: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							HPA052646	Approved									"HPA052646: AB_2681899"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.61e-4)"	"unprognostic (4.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.45e-3)"	"unprognostic (6.87e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.73e-2)"	"unprognostic (4.76e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.10e-2)"	3.0	0.8	0.1	5.5	0.3	0.1	2.7	0.1	0.6	13.6	21.6	0.5	10.2	1.4	20.2	6.1	13.5	11.6	14.4	24.3	0.1	0.1	0.9	0.1	1.8	0.3	1.2	0.3	5.0	0.3	0.1	0.3	2.3	1.3	11.6	2.2	5.4	2.1	14.6	72.6	1.2	4.4	55.7	0.5	0.5	7.3	1.5	0.1	0.0	0.9	11.8	1.8	22.1	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.1	0.6	0.2	0.0	0.3	0.3	1.5	2.0	3.7	4.9	2.2	12.8	5.3	0.0	16.1	16.2	9.4	0.0	0.4	2.0	0.0	0.0	0.0	10.6	0.0	0.2	0.0	0.0	0.8	0.9	2.5	3.7	0.0	0.0	0.0	6.7	3.8	0.0	0.1	0.2	1.2	1.7	3.3	0.0	0.3	0.0	0.0	0.0	10.8	3.2	0.0	10.5	0.0	0.2	2.1	2.3	0.3	4.3	0.0	0.0	0.0	0.2	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.6	0.1	0.1	1.2	0.3	1.3	0.1
KCNE4	MiRP3	ENSG00000152049	"Potassium voltage-gated channel subfamily E regulatory subunit 4"	Q8WWG9	2	223051814-223198399	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 27.0"	"Cell line enriched"	"Detected in some"	4	"AN3-CA: 59.6"	"Cancer enhanced"	"Detected in all"		"breast cancer: 20.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011420	Approved		Approved	"Nuclear bodies,Microtubules"				Microtubules	Microtubules	"HPA011420: AB_1079170"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-3)"	"prognostic unfavourable (9.42e-5)"	"unprognostic (2.17e-2)"	"unprognostic (7.56e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.89e-2)"	"prognostic unfavourable (2.02e-7)"	"unprognostic (4.70e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.24e-3)"	"unprognostic (9.08e-3)"	9.0	2.4	5.5	7.5	5.7	0.2	6.6	2.6	11.9	4.5	3.3	1.2	1.4	0.8	21.9	4.4	3.7	3.4	14.8	3.5	6.5	2.5	2.4	3.6	2.1	3.3	9.4	0.7	9.2	6.4	0.7	5.3	4.6	8.7	3.7	1.4	11.6	2.3	4.2	2.1	2.1	2.3	27.0	21.5	4.7	4.9	2.2	8.4	0.0	5.2	1.7	0.6	7.7	12.5	0.7	0.3	2.3	0.3	0.4	0.3	0.0	0.0	0.3	0.0	59.6	13.7	1.4	0.0	1.4	1.3	0.3	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	2.3	0.0	2.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	2.3	0.0	4.4	0.2	0.0	0.0	0.0	1.4	0.0	1.1	2.3	0.3	0.2	0.3	0.1	0.3	0.2	0.3	0.2	0.0	0.7	0.3	0.3	0.9	0.4	0.2	0.3	0.1	0.0	5.5	5.7	2.6	11.9	6.5	2.5	9.4	0.7	8.7	8.4
KCNMB1	hslo-beta	ENSG00000145936	"Potassium calcium-activated channel subfamily M regulatory beta subunit 1"	Q16558	5	170374671-170389677	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 55.5"	"Cell line enhanced"	"Detected in some"		"REH: 12.7;SK-BR-3: 3.2;U-937: 5.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 7.0;monocytes: 7.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"														"unprognostic (2.06e-2)"	"unprognostic (2.70e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (4.13e-6)"	"unprognostic (1.08e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.04e-2)"	3.2	1.0	0.6	7.7	0.5	0.7	4.2	0.4	0.6	26.8	34.7	0.8	12.6	2.2	31.3	10.6	29.8	10.9	32.4	2.6	0.6	0.7	1.9	0.4	2.2	1.3	1.1	0.9	8.7	0.5	0.1	0.5	0.9	2.2	29.4	5.0	5.6	5.3	29.3	0.9	1.6	11.4	55.5	1.5	1.1	13.4	8.0	0.6	0.3	1.0	1.5	1.6	43.4	6.4	0.5	7.0	1.4	7.1	0.6	0.3	1.0	0.1	0.2	2.3	0.5	0.2	0.0	0.4	0.3	0.1	0.1	0.0	0.5	0.4	0.2	1.6	0.1	0.2	0.1	0.1	0.1	0.5	0.1	1.5	0.8	0.3	0.0	0.6	0.4	0.3	0.0	0.2	0.4	0.2	0.5	1.0	0.1	0.9	0.0	1.3	0.4	0.2	12.7	0.1	0.3	0.1	0.4	0.5	0.3	0.1	3.2	0.0	0.2	1.3	0.8	0.3	0.5	0.5	0.1	0.8	0.3	0.2	0.2	5.3	0.2	1.3	4.3	0.4	0.2	7.1	0.1	0.2	0.3	0.2	7.0	0.5	0.2	0.2	1.4	0.6	6.0	2.6	0.2	1.0	0.6	0.5	0.4	0.5	0.6	0.7	1.1	0.9	2.2	0.6
KIAA0408		ENSG00000189367	KIAA0408	Q6ZU52	6	127440343-127459391	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.6;smooth muscle: 37.2"	"Cell line enhanced"	"Detected in many"		"AF22: 12.4;SCLC-21H: 31.2;SH-SY5Y: 15.4;U-138 MG: 8.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044035, HPA053341"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA044035: AB_10964274, HPA053341: AB_2732578"	"unprognostic (1.06e-1)"				"unprognostic (4.36e-2)"	"unprognostic (3.06e-1)"		"unprognostic (1.09e-1)"			"unprognostic (8.56e-4)"	"unprognostic (1.00e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.20e-2)"	22.9	3.1	9.1	3.4	6.9	0.0	2.8	12.4	21.0	7.4	12.0	0.6	1.9	1.1	2.6	4.7	16.7	1.1	2.9	2.6	10.2	9.7	0.6	0.7	15.3	0.5	11.5	0.7	3.3	0.5	0.0	6.8	1.1	0.9	20.4	5.0	0.7	1.9	1.7	38.6	0.4	6.7	37.2	13.1	2.0	3.7	3.4	1.2	0.7	1.5	15.4	0.8	25.2	11.3	0.0	0.0	0.0	0.2	0.0	0.9	0.1	0.0	2.8	12.4	0.0	1.1	2.9	0.0	0.3	2.2	1.9	4.4	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	2.9	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.7	0.0	8.1	0.0	0.0	0.0	0.3	2.3	0.0	4.3	0.0	4.2	0.0	0.0	2.1	0.0	0.7	0.0	31.2	15.4	0.0	0.0	0.3	0.0	0.8	0.0	8.5	1.4	0.0	2.0	0.0	0.0	0.0	4.9	0.2	6.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.1	6.9	12.4	11.8	10.2	9.7	11.5	0.7	0.9	1.2
LIMS2	"PINCH-2, PINCH2"	ENSG00000072163	"LIM zinc finger domain containing 2"	Q7Z4I7	2	127638381-127681786	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 114.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 11.8;fHDF/TERT166: 13.0;HHSteC: 15.6;MOLT-4: 17.7;TIME: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 17.1"	"Group enriched"	"Detected in many"	14	"B-cells: 17.1;T-cells: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058340	Enhanced		Supported	"Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"HPA058340: AB_2683683"	"unprognostic (2.51e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.51e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.49e-1)"	"prognostic favourable (6.53e-7)"	"unprognostic (3.98e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.86e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.60e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.00e-2)"	21.9	4.4	3.4	16.7	4.5	0.2	17.9	1.5	5.8	31.7	83.5	4.6	18.1	6.5	49.9	17.4	28.3	23.8	31.8	40.2	4.2	1.8	11.7	8.0	20.1	4.9	3.7	4.3	8.2	2.9	2.6	2.8	11.6	6.4	30.6	6.6	20.4	8.0	45.1	12.5	5.7	16.9	114.4	4.0	21.6	25.6	6.8	2.7	11.5	9.3	6.5	4.5	65.1	44.9	17.1	0.8	0.3	0.2	0.0	8.2	1.9	0.3	0.7	0.2	0.0	2.1	0.5	0.2	8.6	11.8	9.3	8.6	2.3	0.0	0.0	5.0	13.0	0.0	0.1	0.0	1.9	0.0	0.3	0.0	5.5	1.6	15.6	0.0	0.0	0.1	0.0	3.6	0.1	6.4	0.0	0.0	4.3	0.0	17.7	0.4	0.6	1.1	4.0	0.8	0.4	0.6	0.0	0.0	0.1	1.6	0.8	0.3	0.3	0.0	37.1	0.0	6.2	7.9	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.2	0.0	10.7	3.9	0.8	0.1	17.1	8.2	3.3	0.3	0.0	0.1	0.8	5.2	1.9	3.4	4.5	1.5	5.8	4.2	1.8	3.7	4.3	6.4	2.7
LINGO2	"LERN3, LRRN6C"	ENSG00000174482	"Leucine rich repeat and Ig domain containing 2"	Q7L985	9	27948078-28670286	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 10.5;smooth muscle: 11.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2;hTERT-HME1: 2.3;SH-SY5Y: 13.4;U-87 MG: 2.3;WM-115: 5.9"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	8	"NK-cell: 3.4"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA016633, CAB025361"	Approved									"CAB025361: , HPA016633: AB_1853362"	"unprognostic (1.27e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.98e-4)"	"unprognostic (9.86e-4)"	"unprognostic (7.55e-3)"		"unprognostic (2.67e-6)"	"unprognostic (1.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.74e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.95e-4)"	0.0	0.3	1.8	0.0	1.7	0.0	0.0	1.0	3.4	0.3	0.0			0.0	10.5	1.0	0.0	0.4	1.0	0.0	1.4	4.1	0.6	0.0	0.0	0.0	0.6		0.0	0.0	2.7	0.6	1.8		0.6	0.0		0.0	1.9	0.0	0.0	0.0	11.4	0.3	0.0	0.4	1.8			3.7		0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.4	0.4	1.7	0.0	0.5	0.3	3.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	1.1	0.3	2.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.5	13.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.3	0.0	5.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	1.7										
LMOD1	"1D, 64kD, D1"	ENSG00000163431	"Leiomodin 1"	P29536	1	201896452-201946588	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 199.7;urinary bladder: 165.5"	"Group enriched"	"Detected in some"	10	"ASC diff: 11.1;BJ: 14.3;BJ hTERT+: 23.3;fHDF/TERT166: 11.5;HSkMC: 10.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 43.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028325, HPA028435, HPA030097"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA028325: AB_10600300, HPA028435: AB_10602180, HPA030097: AB_10601223"	"unprognostic (3.84e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.64e-1)"	"unprognostic (6.35e-2)"	"prognostic favourable (2.52e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.15e-2)"	27.4	12.7	1.9	26.7	6.2	0.0	20.5	2.2	1.9	65.6	83.5	1.8	42.7	6.0	84.9	29.0	94.6	33.2	80.7	8.3	1.6	1.6	5.3	1.0	11.0	5.5	2.3	3.2	38.1	1.6	7.4	1.3	10.2	4.1	77.1	12.0	28.9	6.8	63.8	29.5	7.4	20.9	199.7	1.8	6.3	47.0	23.3	0.7	0.0	7.9	12.3	2.7	165.5	39.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	11.1	1.4	0.9	14.3	23.3	0.9	1.1	0.0	0.1	0.0	0.5	11.5	0.2	0.3	0.0	0.3	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.0	10.2	0.0	0.6	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.0	0.3	0.3	0.5	0.0	0.0	0.1	0.5	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.9	6.2	2.2	1.9	1.6	1.6	2.3	3.2	4.1	0.7
LPP		ENSG00000145012	"LIM domain containing preferred translocation partner in lipoma"	Q93052	3	188153284-188890671	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 127.8;urinary bladder: 105.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 28.8;EFO-21: 35.8;U-698: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 18.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011133, HPA017342"	Enhanced		Enhanced	"Focal adhesion sites,Cytosol"		520000	520000	"Focal adhesion sites, Cytosol"	"Focal adhesion sites, Cytosol"	"HPA011133: AB_1853247, HPA017342: AB_1853249"	"unprognostic (1.50e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.43e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.48e-1)"	19.6	4.2	2.7	29.5	2.8	3.1	12.5	3.0	2.7	42.2	29.9	2.1	19.6	5.0	68.6	14.9	59.7	10.0	37.9	9.3	2.6	2.8	10.9	5.3	11.4	6.0	2.8	1.6	26.1	4.4	4.7	3.2	5.2	3.0	37.7	12.8	8.5	7.0	28.4	11.6	5.9	17.2	127.8	3.2	9.5	12.1	30.7	1.5	5.1	5.4	4.2	7.8	105.1	38.3	5.9	4.9	18.0	4.5	4.3	5.0	1.4	7.5	7.0	5.1	3.4	11.1	11.4	5.5	4.9	6.3	3.6	2.4	12.6	3.6	28.8	35.8	11.2	3.2	1.5	3.3	9.1	3.1	1.7	1.4	5.4	3.3	4.7	0.6	1.7	8.1	4.7	8.1	7.0	6.1	0.0	0.6	6.3	2.4	1.4	0.6	2.0	2.3	1.8	3.8	0.1	4.0	8.0	0.3	0.0	10.6	3.5	6.0	2.7	2.4	13.1	8.4	6.5	6.0	12.2	0.0	1.1	59.7	4.2	1.3	7.6	0.8	4.5	1.9	5.0	4.2	3.2	2.9	4.3	3.6	2.4	5.9	2.3	2.9	18.0	4.3	4.0	4.9	1.6	1.4	2.7	2.8	3.0	2.7	2.6	2.8	2.8	1.6	3.0	1.5
MAB21L2		ENSG00000181541	"Mab-21 like 2"	Q9Y586	4	150581922-150584693	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.2;intestine: 59.8;smooth muscle: 15.2"	"Group enriched"	"Detected in some"	17	"HHSteC: 7.0;SH-SY5Y: 17.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.3"	"Region enriched"	"Detected in some"	18	"pons and medulla: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049324, HPA059864"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA049324: AB_2680712, HPA059864: AB_2684147"	"unprognostic (1.12e-1)"		"unprognostic (3.67e-2)"		"unprognostic (4.03e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.85e-2)"		"unprognostic (8.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.68e-1)"	0.6	3.1	0.2	8.6	0.4	0.0	0.1	0.2	0.2	0.2	59.8	0.1	0.0	6.8	0.1	0.9	0.9	0.2	0.5	0.7	0.2	0.6	0.1	0.5	0.1	0.6	1.0	0.0	0.1	0.2	0.0	0.3	0.0	19.2	0.2	8.1	9.0	2.2	0.0	0.3	0.2	14.7	15.2	4.5	0.1	0.3	0.1	0.0	0.2	1.4	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	17.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	0.6	1.0	0.0	19.2	0.0
MOB2	HCCA2	ENSG00000182208	"MOB kinase activator 2"	Q70IA6	11	1469457-1501247	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 57.3;urinary bladder: 51.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046313	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	Nucleoli	"HPA046313: AB_10959882"	"unprognostic (5.02e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.24e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavourable (4.64e-4)"	"unprognostic (8.30e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.80e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.87e-1)"	"prognostic favourable (2.02e-4)"	"unprognostic (2.67e-1)"	"unprognostic (8.56e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.15e-1)"	9.2	4.2	2.4	17.0	2.5	3.0	12.1	2.5	3.2	14.9	30.9	1.8	6.7	2.5	12.5	8.7	17.3	13.8	26.8	8.1	2.8	1.9	3.2	3.0	4.1	8.2	2.1	2.1	8.6	5.8	6.8	1.8	4.2	2.9	21.2	6.7	4.3	12.9	20.1	7.1	9.4	10.6	57.3	2.5	3.7	9.9	4.2	2.0	2.0	4.3	3.2	4.4	51.8	21.2	10.6	10.8	11.2	12.5	11.6	17.3	9.0	13.9	15.2	9.4	7.6	23.6	16.6	8.7	11.0	16.1	21.3	16.8	9.7	19.2	10.3	8.5	25.9	17.1	14.6	24.8	13.0	13.8	21.8	7.8	5.5	12.3	15.9	10.2	12.3	13.4	29.8	11.3	13.4	22.5	12.6	10.7	10.8	9.9	13.2	17.4	11.6	14.2	9.6	9.7	10.7	17.7	13.4	17.6	18.8	13.7	17.2	13.3	7.9	10.3	18.5	13.0	6.6	4.2	7.0	10.6	10.3	10.7	9.0	9.9	9.9	8.2	8.6	11.2	17.3	8.7	14.6	8.2	14.9	13.8	10.8	10.6	12.5	10.5	7.1	11.6	12.5	6.9	12.8	9.0	2.4	2.5	2.5	2.5	2.8	1.9	2.1	2.1	2.9	2.0
MOXD1	"dJ248E1.1, DKFZP564G202, MOX"	ENSG00000079931	"Monooxygenase DBH like 1"	Q6UVY6	6	132296055-132401545	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 57.2;smooth muscle: 41.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 37.6;ASC TERT1: 30.3;BJ: 22.9;fHDF/TERT166: 42.6;HBF TERT88: 27.5;U-2197: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	47	"memory B-cell: 4.9;naive B-cell: 2.8;plasmacytoid DC: 7.8"	"Group enriched"	"Detected in many"	58	"B-cells: 4.9;dendritic cells: 7.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035740	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA035740: AB_10610141"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.87e-3)"	"unprognostic (5.62e-2)"	"prognostic favourable (7.09e-5)"	"unprognostic (5.77e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavourable (3.72e-4)"	"unprognostic (2.92e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.73e-2)"	1.9	19.5	13.4	3.8	12.5	0.2	1.4	0.3	16.0	17.2	7.7	6.7	7.3	2.7	57.2	7.8	17.4	1.9	15.1	3.2	9.8	1.1	21.4	1.2	15.3	2.9	1.0	6.4	2.4	1.7	0.1	4.3	3.3	0.2	17.6	4.9	0.9	10.6	21.5	0.4	7.4	4.5	41.1	0.8	3.2	3.1	3.1	4.6	0.8	1.5	7.7	7.7	9.4	8.6	4.9	7.8	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.9	0.0	37.6	30.3	0.0	22.9	15.6	8.4	14.7	0.0	0.2	0.1	0.0	42.6	0.0	0.3	0.1	27.5	0.0	4.2	0.0	0.0	0.0	0.3	0.0	0.0	7.2	0.0	16.9	0.5	0.0	0.0	1.7	4.9	0.0	0.0	0.0	0.7	0.1	0.2	0.1	0.0	10.3	0.0	0.6	0.0	0.0	0.1	0.5	0.0	1.2	0.1	3.9	3.6	68.2	11.9	0.9	0.0	0.0	9.7	0.0	11.2	0.0	0.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.3	13.4	12.5	0.3	16.0	9.8	1.1	1.0	6.4	0.2	4.6
MRGPRX2	MRGX2	ENSG00000183695	"MAS related GPR family member X2"	Q96LB1	11	19054455-19060681	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"smooth muscle: 9.2"	"Cell line enriched"	"Detected in single"	4	"U-266/84: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"gdTCR: 2.0"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.0"									HPA055220	Approved									"HPA055220: AB_2682743"						"unprognostic (1.56e-2)"											"unprognostic (1.79e-1)"	5.2	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.0	2.8	0.5	0.0	0.0	0.0	2.0	1.0	0.7	0.1	2.9	0.1	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.7	1.1	0.0	1.3	0.0	0.3	4.3	0.5	9.2	0.0	0.3	0.4	0.8	0.0	0.0	0.0	1.6	0.4	2.8	2.2	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.4	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MSRB3	"DFNB74, DKFZp686C1178, FLJ36866"	ENSG00000174099	"Methionine sulfoxide reductase B3"	Q8IXL7	12	65278643-65491430	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 75.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 37.7;U-937: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 23.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014432	Uncertain				"Intracellular and membrane"					"HPA014432: AB_1854146"	"unprognostic (1.40e-2)"	"prognostic unfavourable (3.84e-4)"	"unprognostic (2.86e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.33e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (8.85e-8)"	"unprognostic (3.29e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (2.17e-4)"	15.2	3.8	4.5	11.6	5.3	6.4	26.8	5.1	5.2	19.0	39.4	3.6	20.4	4.0	40.3	15.0	23.0	16.1	23.4	30.9	4.8	4.3	4.1	1.4	11.7	4.4	5.0	5.0	13.3	2.5	0.8	3.1	8.7	4.7	19.8	10.2	11.8	4.7	38.4	32.2	3.8	10.0	75.9	5.0	6.5	17.2	6.1	4.8	0.4	6.0	11.2	2.5	33.9	20.9	0.2	6.5	23.4	0.6	4.4	0.1	0.8	2.6	5.7	5.0	23.2	22.5	19.9	0.1	26.2	28.2	10.2	6.1	0.2	0.3	0.0	5.6	37.7	0.5	2.3	6.6	9.3	0.0	4.8	0.0	5.1	0.2	14.7	13.7	0.1	10.5	3.7	8.6	12.1	20.7	0.1	0.1	23.4	0.8	0.0	3.2	1.6	3.1	0.0	6.8	0.1	2.3	0.3	0.1	2.4	9.0	0.5	6.4	4.2	13.2	23.7	13.1	7.1	5.9	10.1	2.4	1.9	0.0	3.6	31.8	8.1	6.3	0.3	23.4	0.1	0.6	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.1	4.0	4.4	0.2	6.5	0.0	0.8	4.5	5.3	5.1	5.2	4.8	4.3	5.0	5.0	4.7	4.8
MYH11	"SMHC, SMMHC"	ENSG00000133392	"Myosin heavy chain 11"	P35749	16	15703172-15857033	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 507.4;urinary bladder: 394.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.5;NB-4: 3.8;U-698: 9.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 173.2"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 54.5"	"CAB002302, HPA014539, HPA015310"	Enhanced		Supported	"Plasma membrane,Cytosol"		130000000	130000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB002302: AB_563902, HPA014539: AB_1234906, HPA015310: AB_1854261"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.21e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"prognostic favourable (1.10e-5)"	"unprognostic (1.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.45e-3)"	13.2	3.0	0.6	31.5	1.2	0.0	5.9	0.5	1.7	90.3	227.5	1.3	100.0	11.6	102.0	38.4	233.0	43.8	94.3	6.2	0.6	0.7	4.7	0.7	8.5	1.5	1.4	2.6	45.5	1.3	0.0	1.0	5.3	3.6	164.7	22.2	37.0	8.8	127.2	6.4	5.0	50.6	507.4	1.4	3.7	77.7	22.3	0.2	0.1	3.7	6.2	3.0	394.5	57.5	1.5	0.9	6.0	0.9	1.1	1.5	0.4	0.1	0.4	0.2	0.1	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.4	0.4	0.2	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.3	0.3	3.8	0.4	0.1	0.4	0.1	1.9	0.0	0.2	0.7	1.4	0.2	0.5	1.2	0.4	0.0	0.3	0.1	0.3	2.0	0.1	0.4	0.4	9.7	0.4	0.4	0.4	3.1	0.9	2.7	1.2	0.6	1.2	1.5	1.5	1.4	0.5	1.2	1.4	1.4	6.0	1.1	0.6	0.9	1.4	0.4	0.6	1.2	0.5	1.7	0.6	0.7	1.4	2.6	3.6	0.2
MYL9	"LC20, MLC2, MRLC1, MYRL2"	ENSG00000101335	"Myosin light chain 9"	P24844	20	36541484-36551447	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 717.2;urinary bladder: 496.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 85.0;BJ: 110.2;fHDF/TERT166: 87.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.6;neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA039262, HPA045244, HPA059197"	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center"		92000000	92000000	"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA039262: AB_2676418, HPA045244: AB_2679269, HPA059197: AB_2683944"	"unprognostic (1.15e-1)"	"unprognostic (5.05e-2)"	"unprognostic (2.67e-3)"	"unprognostic (5.38e-2)"	"unprognostic (7.17e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavourable (7.92e-7)"	"unprognostic (1.90e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-2)"	61.9	46.0	2.0	58.1	5.8	0.2	64.8	1.4	6.4	123.3	361.6	6.0	162.9	22.7	278.8	102.0	242.7	80.3	199.0	169.8	1.9	2.1	27.7	6.8	36.0	14.9	4.7	8.7	107.8	5.4	2.8	4.8	31.7	10.5	218.9	30.4	71.8	22.6	203.9	22.2	14.7	70.3	717.2	5.2	22.8	120.7	55.1	1.4	1.4	48.8	21.9	8.7	496.7	107.7	1.2	0.5	2.7	0.2	0.3	0.1	10.8	8.0	0.1	6.4	0.1	85.0	32.7	28.3	110.2	47.7	57.7	37.5	63.5	0.9	0.0	57.8	87.5	3.0	0.0	0.2	13.6	0.0	0.0	1.6	12.4	5.9	54.9	0.0	1.9	45.7	5.8	38.1	0.1	2.0	0.2	2.9	48.4	0.0	0.0	0.8	2.5	0.5	0.0	0.0	0.5	0.4	0.6	0.0	0.4	1.1	2.8	0.0	24.6	1.6	14.1	55.2	23.3	8.0	0.1	0.0	0.4	0.2	20.9	0.0	0.0	0.0	0.2	2.6	0.0	0.0	0.1	1.2	0.0	0.1	0.3	0.2	0.0	0.0	2.7	0.3	0.0	0.5	0.0	10.8	2.0	5.8	1.4	6.4	1.9	2.1	4.7	8.7	10.5	1.4
MYLK	"MLCK, MLCK1, MYLK1, smMLCK"	ENSG00000065534	"Myosin light chain kinase"	Q15746	3	123610049-123884331	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 191.1"	"Cell line enhanced"	"Detected in many"		"BJ: 36.5;BJ hTERT+: 55.2;fHDF/TERT166: 45.0;HBF TERT88: 29.0;RPTEC TERT1: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"basophil: 3.6;classical monocyte: 1.3;myeloid DC: 2.8;neutrophil: 4.5;plasmacytoid DC: 2.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.8;granulocytes: 4.5;monocytes: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020789, HPA031677, HPA048055"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		3000000	3000000	"Actin filaments"	"Actin filaments"	"CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543"	"unprognostic (2.80e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (2.04e-6)"	"unprognostic (5.26e-3)"	"unprognostic (9.60e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavourable (4.46e-4)"	14.9	4.9	4.5	19.8	10.9	0.0	14.4	0.8	5.8	77.1	107.3	22.0	93.2	9.4	111.2	48.3	96.0	56.3	40.6	6.6	4.7	3.2	8.3	5.4	13.2	6.5	25.8	2.8	50.2	1.6	0.5	1.1	8.0	16.0	85.1	27.6	6.0	17.6	158.6	1.6	4.8	33.3	191.1	28.8	7.4	38.7	17.4	13.0	0.2	4.1	2.5	3.4	137.1	21.3	0.2	2.8	4.5	1.3	0.0	0.2	17.3	2.5	7.7	2.1	1.3	2.1	0.4	0.9	36.5	55.2	23.6	17.0	1.6	1.4	0.1	8.2	45.0	0.9	0.9	0.3	29.0	0.0	0.1	20.3	0.2	5.0	11.0	0.1	1.9	6.8	0.7	4.6	6.9	1.8	0.2	0.1	17.5	0.3	0.0	0.5	2.2	1.0	2.3	1.2	6.6	59.6	1.4	0.3	1.1	3.7	0.4	0.6	0.2	0.0	6.7	7.2	2.6	1.7	5.9	0.6	0.7	0.0	18.5	0.2	1.8	3.6	1.3	0.3	0.1	0.2	0.0	0.2	0.0	0.0	2.8	0.1	0.2	0.1	4.5	0.0	0.0	2.7	0.1	17.3	4.5	10.9	0.8	5.8	4.7	3.2	25.8	2.8	16.0	13.0
MYOCD	MYCD	ENSG00000141052	Myocardin	Q8IZQ8	17	12665890-12768949	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 63.4"	"Cell line enhanced"	"Detected in some"		"BJ: 6.8;BJ hTERT+: 6.8;HBF TERT88: 11.3;hTEC/SVTERT24-B: 12.5;REH: 8.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"cerebellum: 6.4"	"CAB046485, HPA071528, HPA072582"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB046485: AB_10600720, HPA071528: , HPA072582: "	"unprognostic (2.82e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.79e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.15e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (2.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.91e-2)"	3.1	0.8	0.6	5.1	1.0	0.0	1.9	0.3	0.5	19.6	19.9	0.2	17.6	2.1	16.6	10.9	14.4	7.4	12.2	18.6	0.4	0.4	0.9	0.4	2.5	0.0	0.5	0.8	10.6	0.4	0.0	0.5	2.6	0.6	17.2	4.2	5.1	0.4	18.7	1.2	1.5	6.6	63.4	0.6	0.5	6.7	3.7	0.1	0.0	1.0	1.2	0.0	33.4	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.8	6.8	2.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.3	0.0	12.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	8.6	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.3	0.5	0.4	0.4	0.5	0.8	0.6	0.1
MYZAP	"GCOM1, Gup, Gup1, MYOZAP"	ENSG00000263155	"Myocardial zonula adherens protein"	P0CAP1	15	57591941-57685364	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 132.6;smooth muscle: 52.2"	"Cell line enriched"	"Detected in some"	4	"HEL: 52.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebellum: 6.9;pons and medulla: 6.1"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 6.7;naive CD4 T-cell: 3.6"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA039827	Approved									"HPA039827: AB_10673364"	"unprognostic (1.30e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.26e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.10e-3)"	"unprognostic (5.19e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.77e-2)"	11.8	12.3	0.6	1.4	1.2	0.5	13.0	6.9	1.0	5.5	5.6	0.6	3.3	3.3	6.1	1.9	12.6	1.1	3.2	132.6	0.6	0.9	1.4	0.4	9.8	2.1	0.9	0.5	1.5	7.4	0.0	1.0	11.7	6.1	13.0	2.4	0.0	6.1	8.4	3.3	2.2	9.1	52.2	0.5	2.4	4.9	1.6	0.2	0.4	1.0	6.6	6.4	31.4	12.1	6.7	0.1	1.0	1.3	0.0	3.6	5.0	2.2	0.7	0.0	4.2	0.9	0.0	1.2	0.3	3.5	0.5	0.7	2.9	1.6	0.0	0.2	0.0	0.9	0.0	1.6	0.7	0.0	0.1	52.2	0.6	0.0	0.1	0.0	0.0	0.0	1.3	0.1	9.6	11.5	0.7	0.0	0.3	0.8	0.0	0.0	0.0	1.0	0.0	4.4	0.1	0.0	10.1	0.0	1.5	0.2	2.3	0.0	3.1	0.0	12.3	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.7	0.6	0.0	0.1	6.7	3.6	0.0	1.0	0.0	1.3	0.0	0.3	5.0	0.6	1.2	6.9	1.0	0.6	0.9	0.9	0.5	6.1	0.2
OSBPL10		ENSG00000144645	"Oxysterol binding protein like 10"	Q9BXB5	3	31657890-32077580	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 39.6"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 31.4;RPTEC TERT1: 33.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"memory B-cell: 11.5;naive B-cell: 6.6"	"Lineage enriched"	"Detected in single"	22	"B-cells: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003636			Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Plasma membrane, Cytosol"	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA003636: "	"unprognostic (5.28e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (2.15e-1)"	"prognostic favourable (1.51e-4)"	"unprognostic (5.86e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavourable (4.85e-4)"	11.7	3.5	3.8	8.7	4.3	1.0	6.7	1.4	7.6	8.6	5.6	0.4	5.9	2.5	11.8	6.7	10.0	5.5	16.7	2.9	2.6	2.6	14.5	1.6	4.6	8.2	3.1	3.6	4.1	2.5	1.3	12.0	16.5	2.5	12.8	6.0	8.5	7.3	16.6	2.0	5.5	7.3	39.6	1.2	9.5	4.4	24.0	1.2	0.4	4.3	4.3	15.1	25.2	11.8	11.5	0.1	0.5	0.0	0.0	0.0	0.2	6.1	3.5	0.6	12.4	1.1	2.3	20.9	1.7	1.9	1.6	2.3	8.6	4.5	14.6	16.7	0.4	3.7	2.7	14.6	1.9	0.1	2.7	0.0	8.6	5.5	0.9	0.0	0.1	2.4	12.4	2.5	31.4	7.1	0.0	0.0	6.8	5.1	0.0	0.0	7.8	8.9	0.1	0.2	0.2	33.1	2.5	0.9	0.1	3.1	5.4	1.7	3.6	0.0	5.0	2.0	21.5	0.2	8.2	1.4	1.0	14.0	2.8	0.0	12.6	0.2	0.0	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	6.6	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.2	3.8	4.3	1.4	7.6	2.6	2.6	3.1	3.6	2.5	1.2
OSR1	ODD	ENSG00000143867	"Odd-skipped related transciption factor 1"	Q8TAX0	2	19351485-19358653	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 68.3;urinary bladder: 62.1"	"Cell line enriched"	"Detected in some"	11	"U-2197: 47.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015525	Uncertain									"HPA015525: AB_1854822"	"unprognostic (1.71e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.85e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.47e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.87e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.62e-1)"	16.9	1.3	0.2	5.0	0.5	0.1	40.0	0.7	1.0	12.6	11.7	0.3	2.0	1.3	9.2	5.6	18.5	4.0	5.7	21.3	0.6	0.2	0.9	0.3	7.9	2.6	0.2	0.8	5.2	2.6	0.2	1.2	3.7	1.5	45.5	1.9	1.6	28.4	3.6	5.9	5.1	5.2	68.3	0.5	0.1	5.1	5.7	0.0	0.1	6.0	7.2	5.0	62.1	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	2.1	1.5	4.4	0.0	2.7	1.2	2.6	1.3	0.0	0.0	0.0	0.0	3.8	0.0	1.3	0.6	0.6	0.0	0.1	0.0	0.0	1.5	1.9	0.0	0.0	2.1	0.0	2.4	3.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	47.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.7	1.0	0.6	0.2	0.2	0.8	1.5	0.0
P2RX1	P2X1	ENSG00000108405	"Purinergic receptor P2X 1"	P51575	17	3896592-3916500	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 98.3;urinary bladder: 60.0"	"Cell line enhanced"	"Detected in some"		"HEL: 12.1;HMC-1: 7.8;Karpas-707: 15.2;THP-1: 12.5;U-937: 6.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 22.4"	"Group enriched"	"Detected in many"	22	"dendritic cells: 8.2;granulocytes: 12.8;monocytes: 22.4"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"midbrain: 2.0"							1300000	1300000				"unprognostic (1.27e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.34e-3)"	"unprognostic (9.89e-5)"	"unprognostic (1.77e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.47e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.09e-2)"	5.2	0.7	0.3	2.9	0.5	17.0	1.1	0.3	0.6	5.9	6.3	0.5	10.7	4.0	4.2	5.2	11.0	2.0	3.0	1.1	0.4	0.3	0.9	0.6	3.8	2.0	0.4	0.5	2.4	29.7	0.0	0.4	1.8	0.5	15.3	4.1	0.7	1.8	16.9	1.0	3.0	4.6	98.3	0.7	6.7	1.4	1.6	0.5	1.5	0.5	1.2	2.7	60.0	5.8	0.6	8.2	12.8	22.4	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.1	0.1	1.0	1.6	7.8	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.2	3.0	0.0	0.0	2.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.1	6.5	0.0	0.0	5.8	6.1	0.0	10.6	0.0	0.2	0.0	0.0	3.2	0.6	0.0	0.0	12.8	0.0	22.4	8.2	0.0	4.5	0.3	0.5	0.3	0.6	0.4	0.3	0.4	0.5	0.5	0.5
PADI3	PDI3	ENSG00000142619	"Peptidyl arginine deiminase 3"	Q9ULW8	1	17249098-17284233	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 10.5;smooth muscle: 9.4;urinary bladder: 28.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.2;RT4: 15.8;T-47d: 11.9"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 48.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043739	Uncertain		Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"HPA043739: AB_10959466"	"unprognostic (4.47e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (3.22e-4)"	"unprognostic (1.05e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.10e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.47e-4)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (1.55e-11)"	"unprognostic (2.40e-2)"	"unprognostic (4.73e-3)"		"unprognostic (2.64e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	5.1	0.0	0.0	3.2	10.5	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.6	6.4	0.0	2.3	0.0	9.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.7	28.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	13.2	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	15.8	0.0	0.0	0.0	2.3	0.1	11.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PALLD	"CGI-151, KIAA0992, SIH002"	ENSG00000129116	"Palladin, cytoskeletal associated protein"	Q8WX93	4	168497066-168928457	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 203.3"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 13.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035905, CAB070159"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Actin filaments"	"Plasma membrane, Actin filaments"	"CAB070159: AB_1726016, HPA035905: AB_2674854"	"unprognostic (3.59e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.03e-3)"	"unprognostic (2.51e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.86e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (3.28e-4)"	17.3	8.9	8.5	19.6	7.5	0.1	28.1	2.1	6.7	58.4	71.9	5.7	46.4	6.7	82.2	25.6	84.3	31.3	30.8	95.0	9.2	3.2	12.7	3.6	24.9	17.0	4.6	4.7	28.0	3.0	25.6	3.9	14.0	6.0	71.4	17.9	9.2	11.4	50.9	30.5	8.9	16.8	203.3	6.7	25.8	31.4	14.1	6.9	2.2	12.7	17.2	5.8	140.3	82.7	0.2	2.2	13.6	3.2	0.6	5.1	1.5	17.6	8.7	19.4	12.0	17.9	19.5	27.3	12.1	30.5	10.7	15.2	0.2	1.0	7.6	3.1	5.2	3.7	11.8	30.8	13.7	16.0	3.6	0.1	25.1	2.2	31.3	0.0	0.2	29.7	19.2	19.1	28.7	4.5	0.0	0.1	64.4	0.8	5.1	0.3	5.6	5.2	1.7	18.0	0.1	1.2	3.5	2.0	10.5	22.8	1.7	1.6	10.8	0.1	14.5	11.2	42.4	4.7	19.6	10.9	0.1	0.3	9.4	0.2	3.1	13.6	3.2	0.0	5.1	1.9	0.2	0.1	0.6	2.7	2.2	0.2	0.6	2.0	0.8	0.6	1.2	0.2	0.5	1.5	8.5	7.5	2.1	6.7	9.2	3.2	4.6	4.7	6.0	6.9
PCDH20	"FLJ22218, PCDH13"	ENSG00000280165	"Protocadherin 20"	Q8N6Y1	13	61409685-61415522	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;smooth muscle: 12.7"	"Cell line enriched"	"Detected in some"	14	"RPTEC TERT1: 33.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062669			Approved	"Vesicles,Cytokinetic bridge"				Vesicles	Vesicles	"HPA062669: AB_2732687"	"unprognostic (2.40e-1)"		"unprognostic (1.80e-1)"		"unprognostic (2.45e-1)"		"unprognostic (7.83e-2)"	"unprognostic (6.79e-4)"			"unprognostic (2.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.34e-4)"	"unprognostic (6.96e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.12e-1)"		0.3	1.6	6.7	0.4	5.8	0.0	1.3	0.0	13.1	3.5	4.5	0.0	0.2	1.2	4.3	4.3	1.8	0.2	0.9	4.8	13.4		1.2	1.8	4.7	0.0	8.8	3.8	0.3	0.1	0.0	0.7	1.3	6.9	1.5	2.5	0.0	0.7	1.5	0.1	0.5	1.4	12.7	8.4	1.6	1.5	0.4	6.3	0.0	0.3	0.0	0.1	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	33.8	0.0	0.5	1.2	0.0	2.3	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PGM5	PGMRP	ENSG00000154330	"Phosphoglucomutase 5"	Q15124	9	68328308-68531061	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 123.0"	"Group enriched"	"Detected in some"	5	"PC-3: 29.9;RH-30: 20.7;SK-BR-3: 25.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 16.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	89	"neutrophil: 8.9"	"Lineage enriched"	"Detected in single"	89	"granulocytes: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB034397, HPA046329, HPA067102"	Enhanced		Uncertain	Cytosol		380000	380000	Cytosol	Cytosol	"CAB034397: AB_1118633, HPA046329: AB_2679625, HPA067102: "	"unprognostic (3.43e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.98e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-4)"	"unprognostic (1.22e-3)"	"unprognostic (2.79e-1)"	"unprognostic (5.28e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.28e-2)"	"prognostic favourable (1.83e-5)"	"unprognostic (3.04e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.73e-2)"	5.9	13.6	0.8	7.5	1.3	0.0	4.1	2.1	1.5	25.9	52.2	1.8	26.1	2.9	36.9	10.3	22.6	20.9	11.1	31.6	1.0	0.4	2.0	1.5	2.7	5.9	0.9	1.3	9.3	1.9	0.5	1.2	1.7	1.3	37.1	7.6	4.3	2.9	51.1	8.5	2.2	15.4	123.0	1.5	1.7	16.6	4.3	0.9	0.9	2.8	4.5	1.5	57.4	24.5	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	4.2	3.4	2.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	5.0	0.0	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.3	0.0	29.9	0.0	20.7	0.9	0.9	0.0	0.0	0.1	0.0	25.9	1.4	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.8	1.3	2.1	1.5	1.0	0.4	0.9	1.3	1.3	0.9
PKD1L3		ENSG00000277481	"Polycystin 1 like 3, transient receptor potential channel interacting"	Q7Z443	16	71929538-71999978	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.9;smooth muscle: 2.9;testis: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (1.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.90e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.35e-6)"	"unprognostic (6.71e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.93e-3)"	0.6	0.5	0.1	2.9	0.1	0.3	0.1	0.1	0.1	0.1	1.0	0.1	0.1	0.7	0.1	0.1	0.1	0.5	0.1	0.2	0.1		0.1	1.2	0.2	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	1.9	2.9	0.1	0.4	0.2	2.1	0.1	0.1	0.1	0.1	0.1	1.2	0.1	0.7	0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.2	0.7	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.6	0.2	0.1	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.4	0.0	0.0	0.8	0.0	0.3	0.4	0.0	0.0	0.9	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.6	0.0	0.0	0.1	0.0										
PLEKHO1	"CKIP-1, OC120"	ENSG00000023902	"Pleckstrin homology domain containing O1"	Q53GL0	1	150149183-150164720	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 60.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061018			Supported	Mitochondria				Mitochondria	Mitochondria	"HPA061018: AB_2684416"	"unprognostic (1.41e-2)"	"unprognostic (7.04e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.23e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavourable (6.47e-11)"	"unprognostic (9.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.52e-2)"	10.9	17.0	14.2	34.4	22.1	10.2	10.5	17.0	14.4	9.6	44.5	5.4	6.4	11.8	16.9	7.7	16.8	11.9	14.1	17.8	10.2	6.9	5.8	5.8	12.9	29.0	8.2	13.1	13.5	2.5	1.4	3.5	10.1	8.0	18.2	8.3	7.9	4.7	12.1	15.8	3.6	17.4	60.7	6.5	29.4	22.3	24.8	7.3	15.0	3.8	3.1	17.4	29.3	17.7	11.0	16.0	18.7	15.8	2.1	5.1	5.4	5.1	1.2	17.2	13.4	5.5	4.9	1.4	8.9	12.3	12.1	10.7	0.3	0.1	0.1	1.7	10.4	0.4	8.6	0.4	3.9	30.6	4.3	0.9	0.7	3.1	10.5	7.0	29.1	7.2	0.4	15.0	2.3	11.4	1.9	13.4	16.4	2.3	26.7	13.9	16.1	2.3	24.2	9.3	5.8	2.0	1.4	10.8	17.6	0.7	0.0	6.7	0.9	7.0	15.9	8.0	9.1	8.2	10.6	5.1	0.1	3.2	31.8	0.0	3.0	1.5	15.8	0.3	3.5	14.1	3.8	11.0	5.1	3.7	11.7	10.5	3.5	3.0	18.7	2.1	12.8	16.0	3.7	5.4	14.2	22.1	17.0	14.4	10.2	6.9	8.2	13.1	8.0	7.3
PRDM6	"KMT8C, PRISM"	ENSG00000061455	"PR/SET domain 6"	Q9NQX0	5	123089121-123194266	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 19.7;smooth muscle: 29.7;urinary bladder: 18.4;vagina: 18.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.8;HEK 293: 9.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"pons and medulla: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA030324	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA030324: AB_10670032"	"unprognostic (2.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.12e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-7)"	"unprognostic (9.30e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-4)"	"unprognostic (1.27e-1)"	1.3	0.3	0.3	0.6	0.3	0.0	1.4	0.4	0.5	1.6	6.7	0.4	0.3	0.4	1.8	0.6	1.2	0.6	19.7	0.9	0.4	0.3	0.6	0.3	10.6	0.0	0.5	0.4	3.8	0.5	0.3	0.5	8.1	3.6	14.1	1.9	0.0	0.3	0.8	0.2	0.4	1.0	29.7	0.8	0.1	1.1	0.5	0.0	0.0	1.4	0.2	0.6	18.4	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.6	0.9	6.8	0.1	0.0	0.0	0.1	0.1	0.3	0.1	0.2	0.5	0.0	1.4	0.0	0.0	0.3	9.6	2.0	0.9	0.0	2.0	0.0	0.3	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	1.1	0.4	0.1	1.5	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.5	0.4	0.3	0.5	0.4	3.6	0.0
PRLHR	"GPR10, PrRPR"	ENSG00000119973	"Prolactin releasing hormone receptor"	P49683	10	118589989-118595699	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 11.3;brain: 10.6;cervix, uterine: 8.3;pituitary gland: 11.8;smooth muscle: 8.1"	"Cell line enriched"	"Detected in single"	9	"SH-SY5Y: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA039361	Enhanced									"HPA039361: AB_10673527"					"unprognostic (1.83e-1)"						"unprognostic (2.62e-3)"	"unprognostic (1.22e-1)"		"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"		0.2	11.3	1.4	0.2	3.0	0.2	0.1	3.2	5.1	8.3	0.2	0.8	0.0	0.3	5.4	0.2	0.2	0.4	0.2	0.1	0.6	4.0	0.1	0.2	0.2	0.1	3.4	0.9	0.1	0.5	0.1	11.8	0.1	10.6	0.3	0.2	0.1	0.2	1.4	0.2	0.2	0.2	8.1	0.5	0.2	0.5	0.2	1.0	0.0	0.2	0.0	0.1	0.1	5.4	0.5	0.4	1.3	0.3	0.7	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.5	0.3	0.2	0.2	0.1	0.2	0.2	0.1	0.2	0.0	0.5	0.3	0.2	1.3	0.7	0.3	0.4	0.0	0.0	1.4	3.0	3.2	1.9	0.6	4.0	3.4	0.9	10.6	1.0
PRUNE2	"A214N16.3, bA214N16.3, BMCC1, BNIPXL, C9orf65, KIAA0367"	ENSG00000106772	"Prune homolog 2"	Q8WUY3	9	76611376-76906087	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 89.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.5;LHCN-M2: 33.6;RH-30: 29.1;RPTEC TERT1: 16.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA022470, HPA031079"	Uncertain									"HPA022470: AB_1845832, HPA031079: AB_10603230"	"unprognostic (1.21e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.43e-3)"	"unprognostic (8.56e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.60e-1)"	"unprognostic (8.69e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.79e-2)"	"prognostic favourable (1.37e-6)"	"unprognostic (7.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.80e-4)"	6.1	18.3	14.1	10.2	28.9	2.6	3.1	47.9	34.5	7.8	45.6	16.4	18.5	5.8	23.9	14.9	26.4	19.0	12.8	5.6	14.6	13.8	12.1	2.2	4.5	2.6	30.4	14.8	3.6	4.0	4.2	22.3	3.7	18.9	37.2	14.9	11.3	10.2	50.8	7.8	2.3	12.5	89.3	19.5	3.8	21.3	4.2	29.5	0.0	1.4	4.6	2.6	38.1	13.8	0.7	1.9	1.8	2.8	1.2	0.6	0.7	0.0	0.0	0.6	0.0	21.5	10.4	0.0	0.7	1.4	2.4	5.9	0.1	0.0	0.1	1.6	1.8	0.0	0.0	0.0	7.5	0.1	1.1	2.5	1.4	0.0	3.5	0.0	0.1	12.0	0.0	10.9	0.3	5.8	0.0	8.5	33.6	0.0	1.7	0.7	1.6	0.0	0.1	29.1	0.1	16.5	0.0	7.2	0.0	0.0	0.1	1.9	0.0	0.3	4.8	5.8	0.3	14.0	0.4	9.1	1.2	0.0	4.7	0.1	0.0	1.2	2.2	0.3	0.1	2.8	0.6	0.0	0.2	0.0	1.9	0.7	0.0	0.0	1.8	1.2	1.2	0.4	0.0	0.7	14.1	28.9	47.9	20.7	14.6	13.8	30.4	14.8	18.9	29.5
PTGIS	"CYP8A1, PGIS"	ENSG00000124212	"Prostaglandin I2 synthase"	Q16647	20	49503874-49568146	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 88.2"	"Group enriched"	"Detected in some"	4	"ASC diff: 17.4;ASC TERT1: 17.5;U-2197: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009517, HPA014193, HPA052244"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB009517: AB_2173209, HPA014193: AB_1855746, HPA052244: AB_2732574"	"unprognostic (7.68e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.22e-2)"	"prognostic unfavourable (4.74e-8)"	"unprognostic (2.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.89e-3)"	"prognostic unfavourable (9.99e-5)"	18.2	2.5	0.6	8.0	1.3	0.1	28.3	0.2	1.6	23.3	14.6	0.5	6.5	1.7	36.5	21.7	13.2	32.0	36.3	23.8	0.3	0.5	3.0	3.8	7.5	1.6	0.5	0.9	51.2	1.3	0.2	0.5	1.0	1.0	27.2	3.7	3.2	3.7	4.6	7.0	3.2	4.4	88.2	1.4	0.3	8.7	16.2	0.3	0.0	6.7	5.6	1.7	64.2	36.1	1.0	0.8	2.7	0.6	0.8	0.5	0.1	0.0	0.0	0.7	0.0	17.4	17.5	0.2	0.3	2.1	0.0	0.0	0.0	0.0	0.0	6.9	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	53.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.6	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.1	1.0	0.4	0.5	2.7	0.8	0.3	0.8	0.2	0.1	0.6	1.3	0.2	1.6	0.3	0.5	0.5	0.9	1.0	0.3
PTGS1	"COX1, PGHS-1, PTGHS"	ENSG00000095303	"Prostaglandin-endoperoxide synthase 1"	P23219	9	122370530-122395703	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 211.4;urinary bladder: 163.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 28.1;ASC TERT1: 22.3;BJ: 27.3;BJ hTERT+: 37.3;HEL: 17.1;HMC-1: 72.7"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 53.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 13.0;granulocytes: 14.4;monocytes: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002834, CAB020315"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	25000000	25000000	"Golgi apparatus"	"Golgi apparatus"	"CAB020315: , HPA002834: AB_1079711"	"unprognostic (4.20e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (8.68e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (9.35e-4)"	4.5	1.1	1.8	9.1	3.1	2.6	2.5	0.5	2.7	2.6	35.3	4.6	3.0	3.9	2.5	1.6	25.7	16.7	9.4	4.9	1.9	1.6	3.9	1.8	4.0	1.4	3.5	0.7	3.6	1.0	0.7	2.4	0.8	2.5	60.9	9.3	1.5	1.9	2.3	0.7	55.9	6.5	211.4	4.9	3.6	7.8	1.0	3.1	0.4	1.5	5.3	4.2	163.9	19.5	2.5	13.0	14.4	8.5	1.9	0.1	13.7	0.0	0.1	0.1	0.0	28.1	22.3	0.0	27.3	37.3	0.2	0.2	0.0	0.0	0.9	1.3	4.6	1.7	0.0	2.5	0.2	0.0	0.0	17.1	0.1	0.0	8.1	1.1	72.7	11.4	0.2	1.4	0.0	10.1	0.0	0.0	0.5	0.0	0.0	1.5	0.3	0.1	0.0	0.3	2.0	3.5	0.0	0.1	0.1	0.1	2.3	0.0	0.0	1.9	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	7.4	0.0	12.0	7.6	14.4	0.0	8.5	0.0	1.7	0.0	0.0	13.0	2.5	0.0	0.0	3.5	1.9	6.1	0.9	0.1	13.7	1.8	3.1	0.5	2.7	1.9	1.6	3.5	0.7	2.5	3.1
PYGB		ENSG00000100994	"Glycogen phosphorylase B"	P11216	20	25248069-25298014	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 101.9"	"Cell line enhanced"	"Detected in all"		"PC-3: 70.3;SK-MEL-30: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031067	Approved		Approved	Cytosol		16000000	16000000	Cytosol	Cytosol	"HPA031067: AB_2673722"	"unprognostic (6.13e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (4.37e-4)"	"prognostic unfavourable (1.10e-4)"	"unprognostic (1.23e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.43e-4)"	19.0	11.3	24.2	12.1	22.9	6.1	28.4	38.3	34.8	14.3	47.0	21.5	19.0	12.5	15.9	13.8	49.6	14.1	21.1	72.5	21.1	21.3	13.5	4.4	14.8	8.1	22.9	24.7	11.9	9.7	8.0	18.2	6.2	28.0	42.2	33.8	11.0	58.4	52.0	5.0	23.9	13.1	101.9	17.8	8.2	24.1	14.5	17.4	9.5	21.1	8.4	10.3	56.7	14.8	4.5	11.2	5.2	16.8	8.1	10.6	16.0	5.2	37.6	6.8	6.6	17.4	32.8	5.0	10.6	13.9	8.9	7.5	8.4	6.5	6.2	12.5	14.1	21.1	7.6	28.2	4.9	3.5	4.7	5.0	3.1	14.4	20.6	7.3	7.0	19.0	26.5	22.7	33.6	11.4	2.7	15.8	12.5	14.5	7.3	5.7	6.1	70.3	5.6	12.3	8.2	48.9	9.6	10.2	6.3	7.2	12.8	88.2	8.9	4.7	25.0	10.6	6.4	11.3	21.5	6.1	9.5	2.4	11.9	5.8	57.6	2.6	10.2	5.2	8.5	15.5	8.3	4.5	6.8	7.5	11.2	4.2	8.8	10.6	2.5	8.1	16.8	5.5	7.5	16.0	24.2	22.9	38.3	34.8	21.1	21.3	22.9	24.7	28.0	17.4
RAB23		ENSG00000112210	"RAB23, member RAS oncogene family"	Q9ULC3	6	57186992-57222314	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 62.4;urinary bladder: 48.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 32.0;U-2197: 56.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029135, HPA029136"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA029135: AB_10602070, HPA029136: AB_10601794"	"unprognostic (8.78e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.46e-3)"	6.0	3.0	6.7	5.7	5.1	0.2	4.0	7.3	4.8	23.1	32.9	5.1	9.6	3.0	34.1	8.0	9.7	8.1	12.4	7.0	7.4	4.5	3.3	1.8	4.9	1.7	6.4	5.4	8.2	1.6	2.9	3.5	12.3	6.7	24.9	7.5	3.6	2.8	26.9	4.7	3.1	7.0	62.4	6.6	1.1	8.7	4.3	7.2	1.4	15.1	3.9	1.7	48.9	11.2	0.3	1.5	1.3	0.6	0.9	2.0	0.3	4.7	1.9	6.8	4.8	10.5	32.0	6.3	14.0	24.3	12.3	12.8	4.1	2.3	0.9	4.4	22.4	1.7	7.1	5.1	14.7	3.5	3.3	3.4	3.1	3.2	6.5	1.8	0.5	11.9	5.9	15.3	14.4	6.4	5.2	2.9	13.6	4.0	1.5	1.9	2.5	2.6	1.7	10.1	1.4	8.5	3.3	3.5	2.4	7.0	3.3	3.6	3.0	2.0	8.5	19.2	6.0	56.4	8.1	2.5	2.8	2.3	10.8	3.8	9.4	0.3	0.4	1.3	0.3	0.4	0.0	0.3	1.1	0.5	0.3	0.3	2.0	0.8	0.0	0.9	0.6	1.5	0.0	0.3	6.7	5.1	7.3	4.8	7.4	4.5	6.4	5.4	6.7	7.2
RBPMS2		ENSG00000166831	"RNA binding protein, mRNA processing factor 2"	Q6ZRY4	15	64739892-64775587	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 75.1;smooth muscle: 69.6;urinary bladder: 51.6"	"Cell line enhanced"	"Detected in many"		"AF22: 16.1;AN3-CA: 22.7;HAP1: 11.7;HEL: 34.2;NTERA-2: 31.4;U-2 OS: 12.1"	"Cancer enhanced"	"Detected in all"		"testis cancer: 37.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.6;naive B-cell: 3.0"	"Lineage enhanced"	"Detected in single"		"B-cells: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (1.68e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.41e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.47e-2)"	"prognostic favourable (1.48e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.68e-3)"	6.9	1.1	0.7	5.8	0.9	0.5	8.3	0.6	1.2	7.0	32.2	1.2	11.5	2.2	13.5	5.7	17.4	7.2	20.5	75.1	1.5	0.6	9.5	3.8	1.7	0.3	1.1	1.1	6.0	1.1	5.5	1.0	2.8	2.1	19.8	3.1	5.9	1.8	17.9	2.4	1.2	7.3	69.6	1.0	1.1	14.7	3.2	0.5	0.2	3.5	2.2	0.3	51.6	12.8	3.0	0.0	0.0	0.0	0.7	0.4	1.8	0.0	2.5	16.1	22.7	0.0	0.0	2.4	0.5	0.0	2.9	0.6	1.9	0.2	0.0	2.2	0.4	0.0	11.7	0.0	1.1	0.0	3.7	34.2	3.8	3.8	1.6	0.0	0.3	0.0	0.0	1.8	0.0	0.2	0.2	0.0	0.2	1.1	0.0	0.1	31.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	5.6	3.4	0.0	0.6	3.2	0.1	0.0	0.0	12.1	1.6	1.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.4	0.0	3.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	1.8	0.7	0.9	0.6	1.2	1.5	0.6	1.1	1.1	2.1	0.5
RTL3	"FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5"	ENSG00000179300	"Retrotransposon Gag like 3"	Q8N8U3	X	78656069-78659328	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 2.5;intestine: 2.6;smooth muscle: 2.7;stomach 1: 3.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 2.4;BJ hTERT+ SV40 Large T+ RasG12V: 2.6;fHDF/TERT166: 4.0;HBF TERT88: 5.4;hTEC/SVTERT24-B: 3.9;RH-30: 4.7;U-251 MG: 3.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA051991, HPA053174, HPA075136"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"				Nucleoplasm	Nucleoplasm	"HPA051991: AB_2681683, HPA053174: AB_2682069, HPA075136: AB_2686737"	"unprognostic (3.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"			"unprognostic (6.74e-2)"		"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.00e-6)"	"unprognostic (1.53e-2)"	"unprognostic (3.64e-1)"		"unprognostic (2.49e-1)"	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	2.6			0.2	2.5	0.2	0.5	0.4	0.5	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0		0.2	0.2	0.0	0.0	0.0		0.2	0.5		0.7	0.0	0.1	0.3	1.1	2.7	0.0	0.0	3.2	0.0			0.1		0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.9	2.4	2.6	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.0	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	1.4	0.2	3.4	0.2	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SBSPON	"C8orf84, RPESP"	ENSG00000164764	"Somatomedin B and thrombospondin type 1 domain containing"	Q8IVN8	8	73064540-73124088	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 66.7;urinary bladder: 47.9"	"Group enriched"	"Detected in some"	8	"BJ: 9.8;RPTEC TERT1: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029595	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	19000	19000	Vesicles	Vesicles	"HPA029595: AB_10600763"	"prognostic favourable (7.18e-4)"	"unprognostic (5.08e-3)"	"unprognostic (3.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.78e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (8.82e-4)"	"unprognostic (6.14e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.25e-2)"	6.7	3.0	0.6	1.7	0.7	0.3	6.7	2.6	0.7	6.5	4.2	2.9	16.5	0.8	4.9	18.1	9.6	8.2	3.0	3.5	1.1	0.8	14.4	0.6	5.0	2.4	2.5	0.9	9.0	1.2	0.0	1.7	9.3	5.4	19.4	1.1	4.3	4.3	25.4	1.1	1.8	2.6	66.7	15.7	1.1	9.9	5.6	0.7	0.1	3.2	2.5	0.9	47.9	7.6	0.9	1.2	1.1	0.4	1.5	0.8	0.3	0.3	0.2	0.5	0.5	0.0	0.0	1.4	9.8	0.0	0.0	0.0	0.1	0.2	0.4	0.5	0.1	0.2	0.0	0.0	0.0	0.3	0.4	0.3	0.4	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.4	0.3	1.0	0.2	0.2	0.2	0.0	17.8	0.1	0.6	0.5	1.0	0.4	0.1	0.2	0.1	0.5	0.2	1.7	0.2	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.7	0.4	0.4	0.6	0.0	0.1	0.4	0.6	0.7	0.1	0.9	0.4	0.8	1.1	1.5	0.4	1.2	0.2	0.3	0.6	0.7	2.6	0.7	1.1	0.8	2.5	0.9	5.4	0.7
SEMA3A	"coll-1, Hsema-I, SEMA1, SEMAD, SemD"	ENSG00000075213	"Semaphorin 3A"	Q14563	7	83955777-84492724	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 24.5"	"Cell line enhanced"	"Detected in many"		"AF22: 42.0;BJ: 32.6;fHDF/TERT166: 35.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 4.7"	"Lineage enriched"	"Detected in single"	15	"monocytes: 4.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029447, HPA052235"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	1200000	1200000	Vesicles	Vesicles	"HPA029447: AB_10602302, HPA052235: AB_2681770"	"unprognostic (1.20e-1)"	"prognostic unfavourable (2.69e-5)"	"unprognostic (1.51e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.92e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.44e-2)"	"unprognostic (6.18e-12)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.47e-4)"	9.6	1.1	2.9	5.2	14.6	0.3	3.7	1.0	6.0	7.4	17.8	1.4	0.7	2.3	1.5	3.3	8.6	3.5	8.6	3.7	2.0	2.1	1.3	1.1	4.9	12.9	1.6	6.5	1.4	1.0	1.3	12.0	14.7	11.1	5.0	8.7	8.2	1.5	0.8	1.0	2.7	5.3	24.5	3.3	17.9	5.4	1.8	1.8	0.0	4.2	1.4	2.4	11.9	2.1	0.0	0.2	0.0	4.7	0.3	0.3	0.0	3.6	10.0	42.0	0.0	1.3	1.0	2.7	32.6	19.2	2.7	1.7	3.5	9.8	0.0	1.5	35.5	18.1	0.1	7.8	3.9	0.0	1.3	0.0	1.8	0.0	1.1	0.8	0.0	1.3	0.0	5.9	1.4	10.2	0.0	0.0	1.1	0.1	0.0	0.0	15.7	3.7	0.7	17.9	1.0	6.1	0.2	3.2	1.7	0.2	0.0	0.3	0.1	0.3	5.7	3.7	3.9	10.5	4.7	2.4	1.6	0.0	3.8	1.4	7.1	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.3	4.7	0.0	0.0	0.0	2.9	14.6	1.0	6.0	2.0	2.1	1.6	6.5	11.1	1.8
SHISAL1	KIAA1644	ENSG00000138944	"Shisa like 1"	Q3SXP7	22	44243667-44312851	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"cervix, uterine: 22.5;endometrium 1: 34.2;smooth muscle: 31.9"	"Cell line enhanced"	"Detected in some"		"SiHa: 16.7;U-2197: 37.9;U-87 MG: 22.0;WM-115: 12.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051178	Uncertain		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"	"Vesicles, Cytosol"	"HPA051178: AB_2681374"	"unprognostic (4.07e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.64e-2)"	"unprognostic (8.10e-3)"	"unprognostic (1.93e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.51e-7)"	"unprognostic (1.48e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.99e-4)"	"unprognostic (1.10e-4)"	0.7	1.3	13.8	1.3	3.6	0.0	0.5	1.6	13.0	22.5	7.7	0.5	6.9	1.4	34.2	4.5	1.5	1.9	2.3	0.5	5.4	9.1	0.5	0.5	0.6	0.5	3.6	0.5	1.7	0.6	0.1	0.8	5.7	0.5	5.8	1.5	0.5	0.5	8.9	0.5	0.4	0.8	31.9	0.5	0.5	0.5	1.5	0.5	0.5	0.5	0.5	0.5	11.9	3.3	0.0	0.1	0.7	0.0	0.2	0.1	0.0	0.0	0.1	1.6	0.5	0.0	0.0	0.0	0.4	1.1	1.1	0.6	0.0	0.0	0.0	0.0	1.0	0.0	2.3	0.1	0.1	0.0	1.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	6.1	0.0	16.7	0.0	0.1	0.0	0.1	0.0	6.2	0.9	37.9	0.2	0.0	0.0	0.0	22.0	0.0	12.7	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.0	0.0	13.8	3.6	1.6	11.8	5.4	9.1	3.6	0.5	0.5	0.5
SLITRK6	FLJ22774	ENSG00000184564	"SLIT and NTRK like family member 6"	Q9H5Y7	13	85792787-85806683	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 24.2;salivary gland: 22.8;smooth muscle: 22.4;urinary bladder: 27.8"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 13.3;RT4: 45.6;WM-115: 10.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 21.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 11.1;cerebellum: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"thalamus: 24.7"	"Low region specificity"	"Detected in many"			"HPA014491, HPA014513"	Uncertain		Supported	"Plasma membrane"		9500	9500	"Plasma membrane"	"Plasma membrane"	"HPA014491: AB_10601603, HPA014513: AB_2669026"	"unprognostic (6.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.46e-2)"	"prognostic unfavourable (8.52e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.82e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.31e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.51e-2)"	0.4	0.3	0.3	2.7	11.1	0.0	2.9	4.9	0.3	1.0	4.5	0.0	0.2	2.8	0.7	3.4	3.6	0.3	1.1	1.9	0.3	1.3	0.3	1.1	3.1	0.0	0.6	0.0	0.3	0.4	0.0	0.4	4.1	0.8	24.2	5.8	1.7	22.8	1.8	0.3	4.5	7.2	22.4	0.4	0.2	1.2	0.5	1.8	0.0	0.6	3.4	0.7	27.8	5.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	2.2	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	13.3	0.0	1.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	45.6	0.4	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	10.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.1	4.9	0.3	0.3	1.3	0.6	0.0	0.8	1.8
SLMAP	"KIAA1601, SLAP"	ENSG00000163681	"Sarcolemma associated protein"	Q14BN4	3	57755450-57929168	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 133.6;urinary bladder: 114.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002357, HPA002358"	Enhanced		Approved	"Endoplasmic reticulum"		12000	12000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA002357: AB_1080023, HPA002358: AB_1080021"	"unprognostic (3.70e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.82e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (7.98e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.06e-1)"	"prognostic favourable (1.58e-6)"	"unprognostic (8.18e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.08e-2)"	10.6	10.7	7.0	22.4	11.1	7.4	12.0	10.2	7.2	26.5	50.3	5.8	24.7	9.8	43.0	19.5	44.0	21.3	15.0	58.2	6.5	5.6	8.0	7.8	8.0	7.2	6.9	6.0	21.4	5.8	16.0	8.0	7.7	6.8	47.8	12.2	8.7	8.6	37.7	26.1	9.4	23.3	133.6	6.0	7.2	27.2	14.9	6.8	11.2	11.1	12.1	6.3	114.2	26.4	5.9	5.1	15.8	5.5	7.1	5.9	4.5	21.8	12.3	10.5	15.2	15.9	16.0	14.4	20.1	20.9	14.2	13.7	29.6	32.5	14.6	9.6	16.0	12.0	18.8	26.9	18.6	16.2	10.8	25.4	17.4	23.1	15.4	25.1	14.2	11.5	21.6	17.4	32.5	16.2	20.7	13.3	14.4	7.1	17.1	12.9	15.8	23.9	7.1	11.6	14.5	29.0	23.8	6.0	7.1	26.3	20.0	12.4	10.8	15.9	19.1	15.7	12.5	19.8	26.1	15.4	26.3	20.0	14.1	21.9	14.6	7.5	5.5	15.8	5.9	3.6	4.9	5.9	4.6	5.0	5.1	4.5	5.4	5.5	13.4	7.1	3.6	2.9	5.1	4.5	7.0	11.1	10.2	7.2	6.5	5.6	6.9	6.0	6.8	6.8
SORBS1	"CAP, FLJ12406, KIAA1296, ponsin, SH3D5, sh3p12"	ENSG00000095637	"Sorbin and SH3 domain containing 1"	Q9BX66	10	95311771-95561414	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 126.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 14.9;HMC-1: 26.0;SK-MEL-30: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 7.6;eosinophil: 2.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027559, HPA043084"	Enhanced		Supported	"Focal adhesion sites,Centrosome"				"Focal adhesion sites"	"Focal adhesion sites"	"HPA027559: AB_10600812, HPA043084: AB_2678307"	"prognostic favourable (2.84e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.01e-3)"	95.0	6.4	23.0	16.4	21.6	1.8	23.5	16.8	22.5	14.9	70.2	18.7	22.1	8.1	41.8	12.5	45.0	25.1	28.9	83.7	20.9	8.3	5.9	14.7	8.7	1.4	13.4	14.1	9.8	7.3	17.5	3.5	9.9	19.2	42.0	20.0	6.4	7.2	65.7	46.4	6.3	15.5	126.5	20.6	2.9	40.0	5.5	19.3	0.0	4.0	12.7	1.2	63.9	31.4	0.1	0.0	7.6	1.2	0.6	1.0	0.2	0.7	0.6	6.3	1.6	2.3	0.1	0.9	0.2	0.0	0.2	0.0	14.9	5.6	0.0	1.2	0.1	0.3	1.1	0.2	0.1	1.7	2.3	3.6	0.2	8.9	0.8	0.0	26.0	0.4	0.2	0.3	0.1	2.6	5.9	1.2	0.6	0.4	0.0	0.3	2.9	1.4	0.5	2.1	0.2	7.0	9.8	2.7	2.0	0.9	0.3	22.3	1.2	0.2	0.2	0.0	2.2	0.1	1.2	0.8	0.2	0.1	2.7	0.2	6.3	7.6	0.2	2.2	0.7	1.2	1.0	0.1	0.3	0.4	0.0	0.1	0.3	0.1	0.2	0.6	0.2	0.0	0.5	0.2	23.0	21.6	16.8	20.7	20.9	8.3	13.4	14.1	19.2	19.3
SYNM	"DMN, KIAA0353, SYN"	ENSG00000182253	Synemin	O15061	15	99098217-99135593	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 111.2;smooth muscle: 147.5;urinary bladder: 85.2"	"Cell line enhanced"	"Detected in many"		"A549: 14.6;HeLa: 21.9;WM-115: 49.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	8	"T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017192, HPA040066, HPA044200, HPA077856"	Enhanced		Supported	"Intermediate filaments"				"Intermediate filaments"	"Intermediate filaments"	"CAB017192: , HPA040066: AB_2676830, HPA044200: AB_2678854, HPA077856: "	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.34e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.27e-2)"	"unprognostic (5.92e-3)"	"unprognostic (3.26e-3)"	6.9	4.2	4.5	5.0	5.4	0.0	11.9	2.5	5.5	2.9	38.4	9.0	27.6	5.4	4.9	7.2	42.1	3.1	9.6	24.8	6.0	5.7	0.8	0.8	2.0	0.7	11.8	4.2	2.9	0.9	1.8	2.0	2.7	8.5	30.1	11.1	10.9	3.2	62.6	111.2	1.5	11.9	147.5	18.2	0.6	16.7	1.5	3.7	0.0	1.4	14.5	1.7	85.2	21.6	0.2	0.1	0.1	0.0	0.2	1.8	0.4	2.5	14.6	3.2	8.7	6.6	0.3	0.2	1.4	2.1	0.8	0.5	2.1	1.9	0.0	2.1	2.1	1.6	2.2	0.0	0.6	0.2	3.6	0.0	21.9	2.1	3.7	0.0	0.4	0.4	0.1	1.4	0.3	1.7	0.0	2.9	2.2	1.4	0.2	0.3	2.9	4.6	0.0	3.0	2.1	0.8	1.4	1.4	1.7	8.6	1.3	5.2	0.0	1.4	1.9	1.6	0.2	1.1	3.4	0.0	0.4	0.0	0.1	0.0	49.6	0.1	0.0	0.0	1.7	0.0	1.4	0.2	1.8	1.1	0.1	0.0	1.6	0.6	0.0	0.2	0.0	0.0	0.0	0.4	4.5	5.4	2.5	4.4	6.0	5.7	11.8	4.2	8.5	3.7
TACR2	"NK2R, NKNAR, SKR, TAC2R"	ENSG00000075073	"Tachykinin receptor 2"	P21452	10	69403903-69416867	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 56.3;smooth muscle: 35.5"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 8.5;U-87 MG: 4.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 6.7"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA076573			Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA076573: AB_2732313"	"unprognostic (2.83e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.72e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.88e-4)"	"unprognostic (5.59e-3)"	"unprognostic (4.31e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.32e-1)"	1.6	0.1	0.5	3.1	0.5	0.1	1.2	0.5	1.1	11.1	56.3	0.2	0.4	4.1	12.3	0.9	19.6	7.2	1.2	1.9	0.5	0.3	0.2	0.5	0.8	0.5	0.2	0.4	2.0	0.8	0.0	0.1	0.1	0.4	14.9	8.2	0.2	0.4	0.9	1.1	0.4	14.2	35.5	0.8	0.5	16.5	0.9	0.5	0.1	0.4	0.8	0.4	19.4	3.1	1.2	2.0	0.5	4.2	0.1	0.8	0.3	1.9	1.2	0.4	0.6	3.0	0.2	0.2	0.5	0.3	0.5	0.7	0.7	0.3	0.2	0.5	0.5	0.7	0.1	0.1	0.0	0.4	0.5	1.6	0.6	1.9	0.3	0.0	3.0	0.5	0.7	0.0	0.0	0.2	0.4	2.5	0.0	0.8	0.1	0.5	0.4	1.9	0.1	0.0	0.0	0.0	1.0	0.8	0.6	1.3	2.6	8.5	1.1	0.2	0.8	3.0	0.4	1.2	1.0	1.2	1.3	0.2	4.9	0.3	1.7	0.5	1.5	0.1	0.3	4.2	0.4	1.2	0.8	0.3	2.0	0.6	0.4	0.2	0.2	0.1	1.7	0.3	0.1	0.3	0.5	0.5	0.5	1.1	0.5	0.3	0.2	0.4	0.4	0.5
TBX20		ENSG00000164532	"T-box 20"	Q9UMR3	7	35202430-35254147	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 26.5;heart muscle: 46.4;prostate: 24.2;smooth muscle: 47.0;urinary bladder: 32.3"	"Cell line enhanced"	"Detected in some"		"HHSteC: 4.7;HMC-1: 5.3;RH-30: 5.2;SH-SY5Y: 9.9;WM-115: 5.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (2.20e-1)"		"unprognostic (1.25e-2)"	"unprognostic (1.87e-2)"				"unprognostic (8.47e-2)"		"unprognostic (3.95e-2)"				"unprognostic (2.75e-1)"	"unprognostic (1.74e-1)"		"unprognostic (9.75e-2)"	0.2	4.3	0.2	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.2	0.2	26.5	46.4	0.2	0.2	0.2	0.6	0.2	0.1	0.2	0.0	0.2	0.2	0.1	1.8	15.1	0.0	24.2	0.1	2.7	0.2	0.1	0.2	0.2	0.2	47.0	0.2	0.2	0.2	0.4	0.0	0.0	0.2	0.0	0.1	32.3	14.4	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	3.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.2	3.1	0.0	0.6	0.0	0.3	4.2	0.0	0.1	2.2	3.4	4.2	1.4	0.0	4.7	0.0	5.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	5.2	0.0	0.1	0.0	0.2	9.9	0.5	0.0	0.0	0.0	3.7	0.0	0.0	0.2	3.6	0.0	0.4	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
THBS4		ENSG00000113296	"Thrombospondin 4"	P35443	5	79991311-80083287	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 69.8;heart muscle: 59.0;skeletal muscle: 61.7;smooth muscle: 94.0"	"Cell line enhanced"	"Detected in some"		"AF22: 5.0;THP-1: 10.7;U-2 OS: 4.6;U-266/70: 4.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	51	"eosinophil: 8.0"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 8.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB004597, HPA042426"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	420000000	420000000	Vesicles	Vesicles	"CAB004597: AB_628352, HPA042426: AB_2677992"	"unprognostic (1.41e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.64e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavourable (3.33e-4)"	69.8	1.0	7.6	2.1	8.3	3.7	9.7	0.8	4.6	1.1	21.4	2.6	1.2	1.3	12.2	13.6	6.5	1.4	4.1	59.0	6.4	6.4	0.8	0.6	1.0	0.9	8.5	1.9	2.1	23.0	5.5	7.8	0.6	10.7	3.7	3.7	4.9	19.8	2.6	61.7	1.5	1.4	94.0	11.5	0.6	4.0	5.5	2.6	2.0	9.9	39.3	4.1	3.4	2.7	0.1	0.0	8.0	0.0	0.0	0.1	0.0	0.2	0.0	5.0	0.3	0.4	2.2	0.5	0.1	0.2	1.5	0.5	0.1	0.6	0.2	0.2	0.4	0.2	0.2	0.6	1.3	0.2	0.7	0.5	0.0	0.3	2.7	0.0	0.1	1.5	0.3	0.1	0.3	0.0	0.0	0.3	0.3	0.7	0.1	0.0	3.9	0.1	0.0	1.5	0.0	0.3	0.1	4.0	1.2	0.1	0.0	0.4	0.0	10.7	0.0	0.1	4.6	0.3	0.3	4.1	0.1	0.7	1.8	3.4	0.9	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	8.3	0.8	4.6	6.4	6.4	8.5	1.9	10.7	2.6
THY1	CD90	ENSG00000154096	"Thy-1 cell surface antigen"	P04216	11	119417378-119424985	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.7;smooth muscle: 91.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 52.6;BJ: 82.2;BJ hTERT+: 92.1;fHDF/TERT166: 144.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003733, CAB068243, CAB068244"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		9800000	9800000	Nucleoplasm	Nucleoplasm	"CAB068243: AB_2665687, CAB068244: , HPA003733: AB_1846340"	"unprognostic (9.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (6.87e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavourable (2.40e-6)"	"unprognostic (1.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.14e-2)"	28.7	5.9	42.0	23.2	72.4	0.4	7.0	17.6	97.7	26.9	9.0	7.2	2.1	3.5	20.3	13.9	9.8	7.5	31.6	4.3	63.4	41.1	46.6	2.6	6.5	10.9	29.8	34.8	3.2	5.0	7.3	5.5	19.1	53.8	4.6	13.6	8.5	2.9	15.7	1.4	4.2	4.6	91.5	9.3	6.7	5.7	4.0	6.9	3.1	12.0	1.0	10.8	36.9	7.2	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.3	12.3	0.0	52.6	38.1	0.0	82.2	92.1	29.5	32.7	0.0	0.0	0.0	0.0	144.0	0.0	0.4	0.1	22.6	7.0	0.0	4.4	1.5	0.0	16.3	0.0	0.0	28.2	0.0	37.4	1.3	0.0	0.0	0.0	22.7	0.0	0.0	0.0	19.7	0.1	0.0	5.8	0.0	0.0	0.0	2.1	5.6	0.0	0.0	0.0	0.1	0.2	0.0	42.4	14.1	12.2	12.1	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	42.0	72.4	17.6	97.7	63.4	41.1	29.8	34.8	53.8	6.9
TNC	"DFNA56, HXB, MGC167029, TN"	ENSG00000041982	"Tenascin C"	P24821	9	115019578-115118257	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 111.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 83.7;hTEC/SVTERT24-B: 68.4;U-138 MG: 57.6;U-87 MG: 76.7;WM-115: 131.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004592, HPA004823"	Approved				"Secreted to extracellular matrix"	760000000	760000000			"CAB004592: AB_628342, HPA004823: AB_1080243"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.68e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.97e-3)"	20.6	2.5	1.4	50.9	11.4	0.5	12.6	0.4	6.4	19.4	63.6	18.6	24.1	5.3	42.4	23.9	18.5	12.0	16.9	13.6	3.4	2.8	16.4	2.6	21.0	66.3	4.3	3.3	10.6	1.8	0.6	3.3	3.2	14.7	13.0	9.3	0.0	8.5	10.8	10.8	10.3	21.2	111.4	5.7	26.9	31.3	5.4	6.8	4.7	5.5	15.4	16.1	20.4	6.6	0.3	0.3	1.9	0.3	0.2	0.3	0.1	2.5	0.6	0.7	0.1	4.1	1.1	0.0	21.5	83.7	45.6	22.5	0.5	5.8	0.0	3.4	30.4	9.0	0.0	1.2	27.4	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.4	0.6	0.1	68.4	31.9	0.0	0.0	0.5	1.2	0.0	0.0	0.0	7.1	9.2	0.0	48.4	0.0	41.5	0.0	0.0	0.6	9.0	0.0	2.1	0.0	0.1	0.0	57.6	9.5	9.9	50.5	1.5	0.0	0.0	76.7	0.0	131.3	0.1	0.3	0.1	0.3	0.1	0.1	0.2	0.2	0.1	0.3	0.3	0.1	0.2	1.9	0.2	0.0	0.2	0.0	0.1	1.4	11.4	0.4	3.9	3.4	2.8	4.3	3.3	14.7	6.8
TNFAIP8L3	FLJ41287	ENSG00000183578	"TNF alpha induced protein 8 like 3"	Q5GJ75	15	51056598-51105276	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 47.0;smooth muscle: 47.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 12.6;ASC TERT1: 32.2;HUVEC TERT2: 27.5;LHCN-M2: 25.8;TIME: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077484	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA077484: AB_2732347"	"unprognostic (1.38e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.12e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.70e-3)"	"unprognostic (6.54e-2)"	"unprognostic (9.35e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavourable (3.51e-4)"	4.6	2.4	11.8	4.1	3.8	0.8	10.5	0.6	5.8	9.8	4.1	1.8	2.8	1.2	47.0	9.9	11.5	20.9	3.7	5.5	11.4	3.1	1.9	1.5	6.6	5.4	1.9	5.6	17.5	1.6	0.6	1.8	1.4	3.3	6.6	5.0	0.6	1.9	3.5	2.1	10.7	3.2	47.0	1.5	14.7	2.9	3.4	1.1	0.0	2.5	4.7	2.4	12.3	18.8	1.4	1.0	3.7	1.5	1.7	0.8	0.3	0.0	0.1	0.0	0.0	12.6	32.2	0.1	0.1	0.0	0.3	0.5	0.0	0.3	0.0	0.6	1.7	0.0	0.4	0.3	0.1	0.0	0.3	0.0	0.9	2.0	3.3	0.1	0.7	11.8	2.5	2.4	9.3	27.5	0.0	0.0	25.8	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.2	36.8	2.9	0.2	9.4	0.7	0.1	0.0	0.0	6.0	0.0	0.0	2.8	1.5	0.7	0.5	0.7	0.6	0.8	0.6	0.5	0.3	1.4	0.6	0.8	3.7	1.7	1.0	1.0	0.4	0.3	11.8	3.8	0.6	5.8	11.4	3.1	1.9	5.6	3.3	1.1
TNS1	"DKFZp586K0617, MXRA6, PPP1R155, TNS"	ENSG00000079308	"Tensin 1"	Q9HBL0	2	217799588-218010421	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 153.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 46.3;ASC TERT1: 25.2;fHDF/TERT166: 21.9;REH: 24.1;TIME: 21.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB018774, HPA036089, HPA036090"	Approved		Enhanced	"Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"CAB018774: AB_2207032, HPA036089: AB_10796111, HPA036090: AB_10794322"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (4.13e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.57e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.71e-3)"	"unprognostic (5.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.49e-2)"	"prognostic unfavourable (5.19e-4)"	77.6	15.6	5.2	21.1	13.7	9.2	33.5	2.9	8.9	50.0	68.9	17.2	45.6	6.0	61.1	29.8	52.0	31.1	46.7	41.0	6.8	4.8	24.0	9.2	28.9	6.1	15.8	4.1	32.3	14.1	6.0	3.8	14.0	14.3	55.1	11.4	27.6	12.8	63.4	40.8	10.1	17.2	153.0	13.7	17.0	30.0	22.6	12.2	1.5	18.3	9.8	4.0	124.6	53.6	0.2	1.0	0.9	1.7	0.0	0.0	2.9	0.0	0.1	3.0	0.0	46.3	25.2	0.3	7.8	2.6	0.4	0.3	3.4	0.0	0.0	4.5	21.9	0.5	0.3	0.4	0.2	3.1	0.2	6.6	1.9	0.9	3.4	0.0	0.8	12.0	0.0	8.3	0.0	10.9	0.2	0.7	6.5	0.9	0.0	0.4	0.3	0.1	24.1	5.8	0.3	1.6	0.0	0.7	3.5	1.3	3.3	0.8	1.1	2.4	21.4	5.7	10.3	5.7	1.7	0.4	0.0	0.0	3.3	0.9	0.4	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.9	0.0	0.7	1.0	0.0	2.9	5.2	13.7	2.9	8.9	6.8	4.8	15.8	4.1	14.3	12.2
TRPC3		ENSG00000138741	"Transient receptor potential cation channel subfamily C member 3"	Q13507	4	121879027-121951754	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 9.3;pituitary gland: 12.0;smooth muscle: 9.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.7;HEL: 5.5;Karpas-707: 5.8;U-2 OS: 3.7;U-251 MG: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.12e-3)"	"unprognostic (9.80e-2)"	"unprognostic (4.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.42e-3)"	1.4	0.4	1.8	0.7	9.3	0.3	0.5	5.8	7.4	3.3	0.8	1.7	0.8	0.8	1.6	1.2	0.6	1.1	7.3	0.5	1.8	2.3	0.7	0.5	2.9	0.5	2.3	1.9	0.8	0.2	0.6	12.0	4.2	7.3	1.1	0.8	0.3	0.8	2.5	0.6	0.5	1.2	9.4	1.1	1.0	0.9	1.6	3.6	0.0	0.6	0.0	0.4	3.6	2.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.3	1.0	1.5	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.9	0.0	0.1	0.0	3.7	5.5	0.1	0.0	0.2	1.5	0.5	0.6	0.0	0.1	0.0	0.0	0.0	5.8	1.2	0.0	1.6	0.0	1.0	0.5	0.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.7	0.0	3.3	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	9.3	5.8	7.4	1.8	2.3	2.3	1.9	7.3	3.6
TRPC4	"HTRP4, TRP4"	ENSG00000133107	"Transient receptor potential cation channel subfamily C member 4"	Q9UBN4	13	37636636-37870425	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.0;smooth muscle: 17.2"	"Cell line enhanced"	"Detected in some"		"AF22: 7.0;BJ: 16.4;BJ hTERT+ SV40 Large T+: 7.0;fHDF/TERT166: 15.6;U-2197: 7.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (4.52e-4)"	"unprognostic (9.99e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.07e-6)"	"unprognostic (3.73e-3)"	"unprognostic (1.93e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.43e-2)"	1.3	0.8	4.6	1.2	4.0	0.2	0.6	2.1	4.0	5.5	4.1	0.6	6.9	0.8	31.0	2.1	0.4	1.9	4.5	1.9	4.8	2.1	3.0	0.5	4.2	0.3	2.5	0.4	3.8	1.8	0.7	0.5	4.6	3.9	9.5	1.1	0.1	0.5	12.6	0.4	0.5	1.6	17.2	2.5	0.5	3.6	0.8	2.5	0.0	1.1	0.0	0.3	3.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	1.1	2.3	0.0	16.4	2.2	7.0	3.8	0.0	0.2	0.0	0.0	15.6	0.0	0.1	0.0	3.5	0.0	0.1	0.0	0.3	0.0	2.7	0.0	0.0	1.0	0.0	2.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.1	7.4	1.4	3.9	0.9	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.0	2.1	4.0	4.8	2.1	2.5	0.4	3.9	2.5
TSPAN2	"FLJ12082, TSN2, TSPAN-2"	ENSG00000134198	"Tetraspanin 2"	O60636	1	115048011-115089500	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 44.6"	"Cell line enhanced"	"Detected in many"		"A-431: 8.4;EFO-21: 34.7;U-937: 15.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons and medulla: 11.9"	"Cell type enhanced"	"Detected in many"		"neutrophil: 35.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 35.0;NK-cells: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015640, HPA073306"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA015640: AB_1858405, HPA073306: "	"unprognostic (4.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.60e-1)"	"prognostic unfavourable (8.89e-4)"	"unprognostic (1.57e-3)"	"unprognostic (1.64e-1)"	"unprognostic (9.73e-6)"	"unprognostic (6.06e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (8.48e-7)"	"unprognostic (5.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.80e-3)"	3.7	0.6	1.1	4.7	2.5	9.6	3.2	0.9	2.0	20.1	31.0	1.5	8.9	2.5	30.6	6.9	12.3	14.2	10.6	6.1	1.1	2.6	4.0	0.6	3.0	1.5	1.9	1.9	6.5	2.0	6.4	2.0	1.5	11.9	15.2	6.2	1.9	2.2	15.7	2.0	1.6	7.0	44.6	1.6	2.2	10.0	4.4	0.8	2.6	4.0	4.9	0.9	25.4	7.0	0.2	1.2	35.0	2.9	25.9	7.4	3.8	8.4	0.1	0.7	0.0	0.0	0.1	0.0	1.4	0.5	1.3	2.2	1.6	5.2	0.0	34.7	1.9	1.2	1.1	0.0	1.5	1.7	0.6	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.5	0.0	0.4	4.5	0.7	7.9	0.9	0.0	0.5	0.0	0.2	3.1	1.8	2.8	2.1	0.9	0.1	0.1	0.3	0.1	0.1	3.4	0.2	8.0	7.2	0.2	0.0	0.0	15.2	3.8	27.8	2.9	16.6	5.9	0.0	1.9	0.2	7.0	7.4	1.2	0.1	1.2	6.0	35.0	25.9	0.0	1.2	0.9	3.8	1.1	2.5	0.9	2.0	1.1	2.6	1.9	1.9	11.9	0.8
TUBA1A	"B-ALPHA-1, FLJ25113, TUBA3"	ENSG00000167552	"Tubulin alpha 1a"	Q71U36	12	49184796-49189324	"Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 270.7;smooth muscle: 166.4"	"Cell line enhanced"	"Detected in many"		"AF22: 222.1;SCLC-21H: 149.7"	"Cancer enriched"	"Detected in all"	9	"glioma: 942.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 151.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008686, HPA039247, HPA043684, HPA063394"	Enhanced		Enhanced	Microtubules				Microtubules	Microtubules	"CAB008686: AB_1624202, HPA039247: AB_2676410, HPA043684: , HPA063394: AB_2685003"	"unprognostic (3.11e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.11e-3)"	"unprognostic (9.79e-2)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.27e-3)"	27.8	25.5	82.1	29.4	81.3	24.7	35.4	63.2	163.0	40.6	48.8	210.9	6.9	9.9	71.7	34.8	27.7	65.3	37.9	26.3	99.3	118.3	10.3	4.2	39.8	13.4	131.0	50.2	35.7	9.9	16.0	20.6	23.1	165.2	35.1	26.7	16.7	13.6	53.4	5.9	20.0	14.5	166.4	270.7	11.6	18.3	15.7	50.4	19.4	7.4	7.3	10.6	35.1	14.5	14.8	28.9	151.2	69.2	7.5	15.7	38.4	0.2	10.0	222.1	31.6	20.2	48.9	0.8	18.7	24.0	12.3	28.7	0.6	4.0	7.9	23.3	60.5	0.4	26.3	6.8	9.6	6.6	9.0	2.6	2.0	2.2	3.9	4.7	0.2	27.5	2.6	24.2	2.5	72.9	3.1	9.0	65.9	4.4	20.1	3.8	23.4	7.4	16.2	15.9	1.0	55.0	0.9	149.7	81.9	5.2	0.3	7.1	15.7	6.4	62.0	13.2	8.3	1.5	5.4	3.1	8.7	15.9	7.2	7.7	13.1	38.8	23.0	73.1	15.7	48.9	11.5	14.8	13.9	14.3	28.9	14.6	13.6	12.5	151.2	7.5	69.2	9.3	15.2	38.4	82.1	81.3	63.2	126.2	99.3	118.3	131.0	50.2	165.2	50.4
